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ABSTRACT 
Objectives:  
1. To enrich the existing information in the field of thyroid diseases. 
2. To study the various modes of presentation, the distribution with respect to 
age and sex, the usefulness of FNAC, and the complications of surgery. 
3. To review the mode of treatment. 
Background Data: 
 Multi-nodular goiter is a commonly used term describing an enlarged 
thyroid gland with multiple areas of nodularity. 
 Worldwide where MNG is the most common endocrine disorder affecting 
500-600 million people.  
 Nodular goitre remains a problem of enormous magnitude affecting no less 
than 5% of the population. Where iron deficiency is the culprit. 
Methods and materials: 
 The present study of “clinical study and management of multinodular goiter” 
has been conducted by utilizing the cases diagnosed clinically as MNG and treated 
on inpatient basis in the department of General Surgery at PSG hospitals 
Coimbatore. It is a prospective study of all the cases clinically diagnosed as MNG 
of about 30 cases. 
Result: Majority of the patients were females with a F : M  ratio of  14:1,with the 
commonest age group being 41- 50 yrs. All patients presented with swelling in 
front of the neck, with other complaints being that of pain, discomfort, and features 
of hyperthyroidism in 1 patient. FNAC was done in all patients and was found to be 
91% accurate.  Majority of the patients were treated with Total Thyroidectomy 
followed by Subtotal Thyroidectomy. Complications included hypocalcemia  and 
RLN palsy. 
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INTRODUCTION 
 Though the thyroid and its diseases were known to the physicians 
from the time immemorial, the subject still continues to evince great interest 
even today from the clinician and the pathologist alike. As Willis stated, for 
the thyroid gland, working in continuous state of interest having alternate 
periods of cellular activity and quittance in response to an array of 
exogenous and endogenous stimuli, it is not so surprising that it suffers from 
a wide variety of disease. A constant supply of thyroid hormones is 
necessary for growth, development and maintenance of metabolism and 
functional activity of most organs. Diseases of thyroid are manifested either 
qualitative and quantitative alterations in hormone secretion or enlargement 
of thyroid (goitre) or both.  
 The gland is slightly heavier in the female sex and enlarges during 
pregnancy and menstruation. 1  
  Nodular goitre is probably the most common endocrine problem in 
the world today. 2  
GOITRE:  
 Worldwide, nodular goitre remains a problem of enormous magnitude. 
It is estimated that no less than 5% of the world's population have goitres. 
Depending on the populat ion studies, multinodular goitre occurs in upto 
12% of adults. Multinodular goitre is more common in women than men and 
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increases in prevalence with age. The incidence of carcinoma in 
multinodular goitre has been reported as 5% to 10%.4 
 Neither a well formulated nor a simple procedure is available for the 
management of patients with MNG. The main reason for such situation to 
exist is, nodular lesions may represent one of the many different cell types 
that cannot be distinguished from one another without histologic study. 5 
 These nodules may be benign or malignant. Ultimately, it is this threat 
of malignancy that poses a major problem. 
 FNAC is a diagnostic tool in which cells are extracted from the 
palpable swelling. Post- operative respiratory complications may need either 
life saving endotracheal intubation followed by tracheostomy or immediate 
tracheostomy. 
Objectives:  
1. To enrich the existing information in the field of thyroid diseases. 
2. To study the various modes of presentation, the distribution with 
respect to age and sex, the usefulness of FNAC, and the complications 
of surgery. 
3. To know the principles and management of MNG. 
4. To review the mode of treatment adopted and to compare and 
correlate the findings of investigations with the final histopathology 
report of the resected specimen.  
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REVIEW OF LITERATURE 
A. HISTORICAL ASPECTS (7,8,9,10)  
 The thyroid gland was previously referred to as a laryngeal gland 
and was subsequently named thyroid by Wharton in 1645, because of 
thyroid cartilage with which it is closed associated. 
Thyroxine (T4) was isolated by Kendall in 1965 and it was 
synthesized by the Harrington   and   Banger    in    1927.    In    1953    the    
important    discovery    of 3, 5, 3 Tri-iodothyronine was made by Cross 
and Pitt-rivers and by Roche, Liesitsky and Michel simultaneously. This 
was proved to be more effective than thyroxine itself. 
Early operations: 
 The first credible account of thyroid surgery was given in              
1170, by Roger Frugardi of Salerno, in the Bamberg manuscripts. 
 By the 19th century the usual indications for surgery were 
suffocationand dysphagia. The overall mortality was over 40% and 
many surgeons advised against operating on goiters and considered it as 
one of the most thankless, most perilousundertakings. 
 The leading thyroid surgeons at this time were Theodor Kocher 
(1841-1917) and Theodor Billroth (1829-1894). Both of them performed 
thousands of thyroidectomies, with progressively better results.  
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 Theodor Kocher was Professor of Surgery in Berne, Switzerland. 
Kocher advocated gentle meticulous surgery that spared yet to be 
discovered parathyroid glands and anatomical appreciation of recurrent 
laryngeal nerve. With application of these principles mortality of thyroid 
surgery decreased from more than 59% to approximately 0.2%. Even more 
important was the discovery by Kocher that total thyroidectomy was 
followed by development of myxoedema and he demonstrated that this 
complication could be prevented by subtotal thyroidectomy. Kocher was 
awarded Nobel Prize in 1909.  
 Since 1970, FNAC as promoted by Perola Granger of Stockholm 
has contributed greatly in early diagnosis of carcinoma. 
 With the development of techniques such as FNAC and ultrasound, 
the performance of thyroidectomy has become selective, unlike in the past 
when surgery was recommended for nearly all Multinodular goitres. 
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DEVELOPMENT OF THYROID GLAND (11) 
 The thyroid gland develops from the epithelial cells in the midline of 
the floor of the pharynx at the level of first pharyngeal pouch. As the 
thickening develops, a process of enfolding takes place. This diverticulum 
becomes an elongated sack attached to the floor of pharyngeal pouch known 
as thyroglossal duct and connects the primitive thyroid structure to the base 
of the tongue, which is being formed at thesame time. The origin of 
diverticulum is marked by foramen caecum. 
  During 6th week of embryonic life, the diverticular thyroid structure 
becomes bilobar and descends to its ultimate position with a lobe on either 
side of trachea in the neck, later these lobes are connected by isthmus. At the 
same time, normally the thyroglossal duct disappears. The ultimo bronchial 
body and internal epithelial body, which are derivatives of forth pharyngeal 
pouch migrate downward and become associated with thyroid. The 
parafollicular C cells are derived from ultimo branchial body.   
 By 8th week of embryonic development, small cavities appear in the 
thyroid tissue. They expand and proliferate, as colloid appears in follicles. 
Formation of follicles is completed by fifth month of fetal life, thereafter the 
new follicles are formed by budding and division of existing follicles. 
Thyroid is the earliest glandular structure to appear. It becomes functional 
during the third month of development of fetus. 
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.  
 
ANOMALIES OF THE THYROID GLAND (12) 
A. Anomalies of shape:  
i. The pyramidal lobe is present so often that it is regarded as a normal 
structure. It may arise from the isthmus or from one of the lobes.   
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ii. The isthmus may be absent.  
iii. One of the lobes of the gland may be very small, or absent.  
B.Anomalies of position  
i. Lingual thyroid: The thyroid may be under the mucosa of the dorsum 
of the tongue and .  
ii. Intra- lingual thyroid: The thyroid may be embedded in the muscular 
substance of tongue.  
iii. Suprahyoid thyroid: The gland may lie in the midline of the neck 
above the hyoid bone.  
iv. Infrahyoid thyroid: The gland may lie below the hyoid bone, but 
above its normal position.  
v. Intrathoracic thyroid: The entire gland, or part of it, may lie in the 
thorax.  
C. Ectopic thyroid tissue: Small masses of thyroid tissue have been 
observed in the larynx, trachea, oesophagus, Pons, pleura, pericardium and 
ovaries. Masses of ectopic thyroid tissue have been described in relation to 
the deep cervical lymph nodes (lateral aberrant thyroids) but these are now 
believed to represent metastases in the lymph nodes from a carcinoma of the 
thyroid gland.  
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D.Remnants of the thyroglossal duct may persist and lead to the formation 
of:  
a. Thyroglossal cysts that may occur anywhere along the course of the 
duct.  
b. Thyroglossal fistula opening at the foramen caecum. c. Carcinoma of 
the thyroglossal duct.  
SURGICAL ANATOMY OF THYROID GLAND13,14,15,16,17 
 Thyroid gland averagely weighs 20-25 Gms. It is larger in females 
than in males and increases further during pregnancy and menstruation. The 
thyroid gland occupies the important position in the central compartment of 
the neck, . The thyroid gland has two lobes connected by isthmus. Each lobe 
is pear shaped consists of narrow upper pole and broader lower pole. The 
lobes occupy the anterolateral surface of trachea extending from the middle 
of thyroid cartilage superiorly up to 6th tracheal ring inferiorly. The right 
lobe is larger than the left. The isthmus lies in the front of 2nd and 3rd 
tracheal rings and attached quite firmly to trachea.  The gland possesses its 
own delicate capsule and fascia propria. It lies within the envelope of 
pretracheal fascia. The superficial surface of the gland is covered by the 
infrahyiod and sternomastoid muscles with its fascial coverings. The medial 
surface is related to the trachea and esophagus, two nerves recurrent and 
external laryngeal nerves, two muscles inferior constrictor and Cricothyroid. 
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The posterior surface overlaps the common carotid artery and covers the 
terminal part of inferior thyroid artery. Isthmus joins the anterior surface of 
lobes towards their lower poles.. A small portion of the gland projects 
upward from the upper border of isthmus, named as pyramidal lobe. It 
represents the distal most part of the thyroglossal duct. Sometimes few 
muscle fibers are attached to it, called levator glandulae thyroidea and it is 
innervated by external laryngeal nerve. 
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Anatomy of the thyroid gland and surrounding structures, viewed 
anteriorly (A) and in cross section (B). 
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BLOOD SUPPLY 
 The thyroid gland is supplied by a pair of superior thyroid arteries, 
inferior thyroid arteries, and solitary thyroidea-ima artery and accessory 
thyroid arteries. 
a. Superior thyroid artery: It is the first branch from the anterior 
surface of the external carotid artery. After giving off sternomastoid 
and superior laryngeal branches, it pierces the pretracheal fascia as a 
single branch and reaches the tip of the upper pole and enters the 
gland superficially.  
b. Inferior thyroid artery: It is a branch of thyrocervical trunk which 
arises from the first part of the subclavian artery. In the neck, it passes 
behind the carotid artery. Before entering the pretracheal fascia, it 
divides into 4 or 5 branches that pierce the fascia separately to reach 
the lower pole of the gland.  
c. Thyroidea ima artery: It enters the lower part of the isthmus in 3% 
of the individuals. It arises from the arch of aorta or innominate artery. 
VEINS 
The thyroid gland is drained by following veins 
a. Superior thyroid vein: It leaves the upper part of the gland, crosses 
the common carotid artery and terminates into the internal jugular vein 
or common facial vein. 
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b. Middle thyroid vein: It leaves the gland at the middle of the lateral 
part of the lobe, follows the inner border of the omohyoid muscle 
across the carotid vessels to end in internal jugular vein. It is thick, 
short and directly enters the jugular vein. It is present only in 30% of 
individuals. 
c. Inferior thyroid vein: It leaves the Isthmus at the inferior border and 
runs down in front of the trachea to end in innominate vein of the 
same side. 
d. Fourth thyroid vein: KOCHER drew attention to the frequent 
existence of this vein which passes outward between middle and 
inferior thyroid vein. 
NERVES RELATED TO THE GLAND 
 The external laryngeal nerve and the recurrent laryngeal nerve are in 
close relationship with the gland. 
a. External laryngeal nerve: It is a branch of superior laryngeal nerve, 
descends on the fascia of the inferior pharyngeal constrictor to supply 
the cricothyroid muscle which is tensor of vocal cords. The nerve lies 
close to the superior pedicle with nerve medial, vein lateral and 
superior thyroid artery between them. Injury to external laryngeal 
nerve results in decrease range of pitch and fatigue in speaking. It may 
or may not cause change in voice. Laryngoscopy reveals normal 
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movement of vocal cord but it is irregular and wavy and the cord lies 
at the lower level and has lack of the tone resulting in bulge on 
expiration and retraction on inspiration. 
b. Recurrent laryngeal nerve: The nerve is branch of vagus nerve 
embryologically related to 4th aortic arch vessels. The nerve lies in the 
tracheo-oesophagal groove and posterior to the inferior thyroid artery. 
The nerve may be lateral (28%) or anterolateral (10%) to trachea. In 
30% of cases, it passes anterior to inferior thyroid artery or may even 
lie within its branches. 
 
 
Relationship of the parathyroids to the Recurrent Laryngeal Nerve 
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In some cases, the nerve will be embedded in the ligament of berry and thus 
it will be drawn forward with the gland traction. Injury to this nerve results 
in partial (abductor) or total paralysis of the cord resulting in hoarseness and 
respiratory difficulty.  
Non-recurrent laryngeal nerve: In 0.63% cases the recurrent laryngeal 
nerve may not recur. The recurrent laryngeal nerve arises from the vagus 
nerve in the neck in the proximity to the 4th primitive aortic arch vessels 
which form the subclavian artery on the right side and aortic arch on the left 
side. The recurrent laryngeal nerve passes caudal these vessels to larynx and 
is therefore dragged caudally when vessels descend.  The non-recurrent 
laryngeal nerve may be mistaken for inferior thyroid artery or middle thyroid 
vein and ligated during thyroidectomy. 
c. Internal laryngeal nerve: It is the branch of the superior laryngeal nerve 
and penetrates the larynx through thyrohyoid membrane. Injury to this nerve 
is exceptional and occurs only when the superior pole is very much enlarged. 
It results in loss of sensation of laryngeal inlet with post deglutition coughing, 
chocking, or aspiration pneumonia. 
CAPSULES: 
 The thyroid gland is surrounded by two capsules, the true capsule and 
a false capsule. The true capsule is made up of condensation of connective 
tissues around the gland while the false capsule is formed by pre-tracheal 
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fascia. The blood vessels pierce both these capsules and thus firmly ramify 
to form a dense vascular plexus beneath the inner or true capsule of the 
gland. The space between the two capsules is traversed by the arterial and 
venous trunks. During operations on thyroid utmost care is taken not to 
injure the true capsule as under it lays the numerous fragile vessels. 
SUSPENSORY LIGAMENT OF BERRY: 
 This is the thickening of pre-tracheofascial investment of thyroid. It 
passes from inner and posterior surface of the gland to cricoid cartilage. The 
two ligaments left and right form a sling, anchoring the gland to the larynx. 
They increase in size in large goitres, thus preventing the gland falling away 
from larynx. The recurrent laryngeal nerve is in immediate contact with the 
back of the ligament. 
LYMPHATICS OF THYROID: 
The gland is drained by two sets of  lymphatics 
1) ascending and 2) descending each consisting of medial and lateral 
channels. 
Ascending Vessels: 
Medial: leave the upper border of the gland and drain into nodes situated on 
the cricothyroid membrane, the prelaryngeal gland.  
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Lateral: leave the upper pole of the gland and run along the superior thyroid 
artery to the deep cervical nodes situated at the bifurcation of common 
carotid artery. 
Descending Vessels: 
Medial: pass to the gland on the trachea, pre-tracheal lymph nodes. 
Lateral: pass from the deep surface of the gland to small nodes placed on 
recurrent nerve, the nodes of recurrent chain. 
 The lymph vessels run in the interlobular connective tissue and 
connect with the network within the capsule of the gland. The ascending 
lymphatic channels drain the upper border of isthmus and surface of the 
lobes. The descending channels drain the major part of isthmus and lower 
part of lateral lobes. The median lymph node near the isthmus is often 
involved in thyroid cancer, which is called Delphian node. 
NERVE SUPPLY OF THE GLAND 
 The bulk of the sympathetic supply is derived from the middle 
cervical ganglion and enters the gland on the inferior thyroid artery. Some 
fibers from the superior ganglions travel with the superior thyroid artery. The 
sympathetic fibers are vaso-constrictor. Vagus nerve also supplies the gland. 
Its purpose is unknown. 
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MICROSCOPIC ANATOMY 
 A section of the gland shows the typical colloid follicles, whose 
appearance depend on the state of activity of the gland. In resting stage 
follicles are uniformly distended with colloid, they are rounded in outline 
and lined by low columnar epithelium. These follicles are arranged in 
subunits of 20 to 40 lobules each being supplied by an individual arteriole. 
These cells secrete thyroxin (T4) and triiodothyronine (T3). Clumps of small 
round cells lie between the follicles, which are parafollicular cells, which 
produce calcitonin. In more active state the colloid is less and follicles are 
uniformly smaller and crinkled in outline. The lining columnar epithelium is 
much taller. 
PHYSIOLOGY 18 
 The thyroid gland maintains the level of metabolism in the tissues that 
is optimal for their normal function. Thyroid hormones stimulate the 0 2 
consumption of most of the cells in the body, help regulate lipid and 
carbohydrate metabolism, and are necessary for normal growth and 
maturation. The thyroid gland is not essential for life, but its absence causes 
mental and physical slowing, poor resistance to cold, and, in children, mental 
retardation and dwarfism. Conversely, excess thyroid secretion leads to body 
wasting, nervo usness, tachycardia, tremor, and excess heat production. The 
thyroid gland also secretes calcitonin, a calcium- lowering hormone.  
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FORMATION AND SECRETION OF THYROID HORMONES  
 The principal hormones secreted by the thyroid are thyroxine (T4) and 
triiodothyronine (T3), T3 is also formed in the peripheral tissues by 
deiodination of T4. Both hormones are iodine - containing amino acids. 
Small amounts of reverse triiodothyronine (3, 3', 5'- triiodothyronine. RT3) 
and other compounds are also found in thyroid venous blood. T3 is more 
active than T4. The naturally occurring forms of T4 and its congeners with 
an asymmetric carbon atom are the L isomers. D- Thyroxine has only a small 
fraction of the activity of the L form. T4 and T3 are synthesized in the 
colloid by iodinat ion and condensation of tyrosine molecules bound in 
peptide linkage in thyroglobulin. This glycoprotein is made up of two sub - 
units and has a molecular weight of 6, 60,000. Thyroglobulin is synthesized 
in the thyroid cells and secreted into the colloid. The hormones remain 
bound to thyroglobulin until secreted. When they are secreted, colloid is 
ingested by the thyroid cells, the peptide bonds are hydrolyzed, and free T4 
and T3 are discharged into the capillaries. Thyroglobulin enters the blood as 
well as the colloid. The normal serum thyroglobulin concentration in humans 
is about 6ng/mL, and this level is increased in hyperthyroidism and some 
forms of thyroid cancer. 
 Iodine Metabolism: Iodine is a raw material essential for thyroid 
hormone synthesis. Ingested iodine is converted to iodide and absorbed. The 
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principal organs that take up the iodine are the thyroid, which use it to make 
thyroid hormones, and the kidneys, which excrete it in the urine. 
 Iodide Trapping: The thyroid concentrates iodide by actively 
transporting it from the circulation to the colloid. The transport mechanism is 
frequently called the "iodide trapping mechanism" or "iodide pump". In the 
gland, iodide is rapidly oxidized and bound to tyrosine. 
 Thyroid Hormone Synthesis: In the thyroid gland, iodide is oxidized 
to iodine and bound in a matter of seconds to the 3 position of tyrosine 
molecules attached to thyroglobulin. The enzyme responsible for the 
oxidation and binding of iodide is thyroid peroxidase, with hydrogen 
peroxide accepting the electrons. Monoiodotyrosine (MIT) is next iodinated 
in the 5 position to form diiodotyrosine (DIT). Two DIT molecules then 
undergo an oxidative condensation to form T4 with the elimination of the 
alanine side chain from the molecule that forms the outer ring. Thyroid 
peroxidase is probably involved in coupling as well as iodination. T3 is 
probably formed by condensation of MIT with DIT.Secretion: The human 
thyroid secretes about 80 µg (103 nmol) of T4, 4 µg (7nmol) of T3. 
However, MIT and DIT are not secreted.  
TRANSPORT AND METABOLISM OF THYROID HORMONES  
Protein Binding: The normal total plasma T4 level is approximately 80 µg 
(103nmol/L), and the plasma T3 level is approximately 4 µg (7nmol/L). 
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Large amounts of both are bound to plasma proteins. The normal Protein-
bound iodine is potent than T4. This is because it is less tightly bound to 
plasma proteins but binds more avidly to thyroid hormone receptors T3 is 
inert.  
1. Calorigenic Action: T4 and T3 increase the oxygen consumption of 
almost all metabolically active tissues. The exceptions are the adult 
brain, testes, uterus, lymph nodes, spleen, and anterior pitutary. 
2. Effects Secondary to Calorigenesis: In hypothyroid children, small 
doses of thyroid hormones cause a positive nitrogen balance because 
they stimulate growth, but large doses cause protein catabolism similar 
to that produced in the adult. Peripheral resistance decreases because 
of cutaneous vasodilation, but cardiac output is increased by the 
combined action of thyroid hormones and catecholamines on the heart, 
so that pulse pressure and cardiac rate are increased and circulation 
time is shortened.  
3. Effects on the Nervous System: In hypothyroidism, mentation is slow 
and the CSF protein level elevated. Thyroid hormones reverse these 
changes, and large doses cause rapid mentation, irritability and 
restlessness.  
4. Effects on the Heart: Thyroid hormones increase the number and 
affinity of P - adrenergic receptors in the heart and consequently 
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increase its sensitivity to the inotropic and chronotropic effects of 
catecholamines.  
5. Effects on Skeletal Muscle: Muscle weakness occurs in most patients 
with hyperthryoidism (Thyrotoxic myopathy) and when the 
hyperthyroidism is severe and prolonged, the myopathy may be 
severe. The muscle weakness may be due in part to increased protein 
catabolism.  
6. Relation to Catecholamines: Thyroid hormones increase the number 
and affinity of p- adrenergic receptors in the heart and possibly in 
some other tissues, and the effects of thyroid hormones on the heart 
resemble those of p- adrenergic stimulation.  
7. Effects on Carbohydrate Metabolism: Thyroid hormones increase the 
rate of absorption of carbohydrate from the gastrointestinal tract, an 
action that is probably independent of their calorigenic action.  
8. Effects on Cholesterol Metabolism: Thyroid hormones lower 
circulating cholesterol levels.  
9. Effects on Growth: Thyroid hormones are essential for normal growth 
and skeletal maturation. In hypothyroid children, bone growth is 
slowed and epiphyseal closure delayed. In the absence of thyroid 
hormones, growth hormone secretions are also depressed, and thyroid 
hormones potentiate the effect of growth hormone on the tissues.  
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REGULATION OF THYROID SECRETION  
 Thyroid function is regulated primarily by variations in the circulating 
level of pituitary TSH. TSH secretion is increased by the hypophysiotropic 
hormone TRH and inhibited in a negative feedback fashion by circulating 
free T4 and T3.  
  When TSH is administered, thyroid function is stimulated. Whenever 
TSH stimulation is prolonged, the thyroid becomes detectably enlarged. 
Enlargement of the thyroid is called goitre. The negative feedback effect of 
thyroid hormones on TSH secretion is exerted in part at the hypothalamic 
level, but it is also due in large part to an action on pituitary, since T4 and T3 
block the increase in TSH secretion produced by TRH. Infusion of T4 as 
well as T3 reduces the circulating level of TSH, which declines measurably 
within one hour. 
D. CLASSIFICATION OF GOITRE  
 Goitre is a clinical term for any visible or palpable enlargement of the 
thyroid gland.  
Different authors have classified goitre in different ways  
 
 
 
  
124 
 
I.Classification by Hamilton Bailey and McNeill Love (19)  
1. Simple goitre (Euthyroid)  
 Diffuse hyperplastic  
Physiological  
Pubertal  
Pregnancy  
Multinodular goitre  
2. Toxic  
Diffuse  
Graves disease  
Multinodular goitre  
Toxic adenoma  
3. Neoplastic  
Benign  
Malignant 
4. Inflammatory  
Auto immune  
Chronic lymphocytic thyroiditis  
Hashimoto's disease  
Granulomatous  
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deQuervain's thyroiditis  
Fibrosing  
Riedel's thyroiditis  
Infective  
Acute (Bacterial thyroiditis, viral thyroiditis, subacute thyroiditis)  
Chronic (Tuberculous, syphilit ic)  
5. Other  
 Amyloid 
II. WHO Classification for endemic goitre: (20)  
 Grade 0: Thyroid not palpable or, if palpable, not larger than normal.  
 Grade la: Thyroid distinctly palpable but usually not visible in 
position; the thyroid is larger than normal, i.e. at least as large as the 
distal phalanx of the subject's thumb.  
 Grade lb: Thyroid easily palpable and visible with the head in a  
 raised position; the grade includes all patients with a discrete nodule.  
 Grade 2: Thyroid easily visible with the head in a normal position.  
 Grade 3: Goitre visible at a distance.  
 Grade 4: Monstrous goitre.  
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III. SIMPLIFIED W.H.O GOITRE CLASSIFICATION SYSTEM (20 ) 
GRADE ‘O’: No palpable or visible goitre.  
GRADE ‘1’: Mass in the neck is consistent with an enlarged thyroid that is 
palpable but not visible when neck is in neutral position, it also moves 
upward in the neck as the subject swallows.  
GRADE ‘2’: A swelling in the neck that is visible when the neck is normal 
position and is consistent with an enlarged thyroid when neck is palpated. 
AETIOLOGY OF MULTINODULAR GOITRE21 
 The hormone synthesis and its release is regulated by TSH, which in 
turn is regulated by TRH. When the levels of T4 and T3 in the blood are low, 
anterior pituitary is stimulated to secrete TSH, which induces hyperplasia 
and hypertrophy of follicular cells to trap iodine and synthesize thyroid 
hormone. The hyperplasia may not occur uniformly, as a result of which 
some foci of hyperplasia are larger and other are small. Following 
hyperplasia, involution occurs as need for T4 and T3 decreases. Repeated 
stimulation causes hyperplasia and involution of varying degrees, also 
degenerative changes and fibrosis resulting in nodularity. Among various 
nodules only one of them attains large size and other will be of small size 
which cannot be detected clinically. The causes leading to deficiency of 
thyroid hormone synthesis are: 
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A) Iodine deficiency: 
 Iodine deficiency in endemic area results in highest incidence of 
goitre. Iodine deficiency alone does not cause goitre. There are other factors 
which play a role in aetiopathogenesis of goitre such as antithyroid agents. 
Concomitant exposure to naturally occurring antithyroid agents magnifies 
the severity of goiter endemicity. Iodine supplement is found to be 
associated with increased incidence of lymphocytic autoimmune thyroiditis. 
B) Goitrogens : 
Chemical goitrogens: 
Anti thyroid compounds may enter through food, water, air becoming an 
important environmental goitrogenic factors in human being. They act as  
additive in endemic iodine deficient areas and responsible for sporadic goitre 
in nonendemic areas. Thiocyanate is also found in high concentration in 
water, effluent of local conversion process, and in body fluids as a  
metabolite of hydrocyanogenic gas consumed while smoking. Thiocyanate 
inhibits iodine concentration mechanism in thyroid gland and its activity can 
be overcome by iodine administration. Isothiocyanate acts by thiocyanate 
pathway and also react with amino groups forming derivatives having 
thiocyanate like antithyroid effect, therefore its activity cannot be 
antagonized by iodine administration. Flavinoids found in millets, sorghum, 
beans, groundnuts exert thiocyanate like antithyroid activity. 
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1. Phenol derivatives: Coal is the source of large variety of antithyroid 
agents and goitrogens like resorcinol, phenol, thiocyanate etc. Most of 
these compounds contaminate water. 
2. Excess iodide: Iodine consumption in greater than 2mg/day inhibits 
proteolysis and release of thyroid hormones and induces iodide goitre. 
Drugs that act as goitrogen: 
 Lithium,Para-amino salicylic acid (PAS), Phenendione, Phenyl 
butazone and Salfonamides. 
C) Genetic defects: Familal goitres 
 Single gene abnormality causes defect in metabolic pathway of T4 
synthesis, which are: 
1. Defect in iodine transport 
2. Defect in organification failure to form organic iodine 
3. Deficiences of enzymes 
4. Lack of iodine peroxidase – complete block 
5. Lack of iodine transferase – incomplete block, relatively common 
6. More than 150 cases reported with consistent association of goitre  
with deaf mutism. Pendred’s syndrome is generally limited to single 
generation. 
7. Coupling defect – Failure to couple iodotyrosines uncommon – 6 
cases. 
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8. reported, more common in females. 
9. Iodotyrosine deiodinase defect - uncommon. 
10. Abnormal serum iodinated polypeptides – rare Autoimmune thyroid 
disease occur more often in Down’s syndrome and also seen in 
Klienfelters syndrome. 
D) Immunological Factors: The 
 Major antigens are TSH receptor (TSH-R), enzyme peroxidase, and 
thyroglobulin. TSH-R is major antigen in Grave's disease. TSH-R(stim) 
Antibodies tend to stimulate the cells. Antibodies to enzyme peroxidase and 
thyroglobulin are hallmark of Hashimoto’s thyroiditis. 
E) Calcium and Fluorine 
 The association of endemic goitres with lime stone formation in hard 
water was noted by many observers over the years leading to hypothesis that 
excessive ingestion of calcium is an aetiological factor. Some experimental 
evidence has been added to indicate that calcium may enhance the 
goitrogenic effect on the diet already deficient in iodine, though, how it acts 
is still a mystery. 
F) Associated with malignancy 
 Radiation exposure to thyroid gland is only well documented risk 
factor that increases the incidence of well differentiated thyroid cancer. 
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 There is 40% chance that patients presenting with a thyroid nodule 
and a history of radiation have thyroid cancer. 
Classification of thyroid nodules 
 There is no universally accepted classification, as the etiology of the 
nodular goitre is presumptuous and pathological appearances are often 
difficult to correlate with clinical features (Alan Newton, 1950). Any 
classification must be workable and usable to clinician and pathologist and 
simple to avoid confusion, so admittable to change and revisions made by 
the newer concepts. (Warren and Meissner 1953). 
Scintiscan classification of nodules 
 With Scintiscan it is possible to classify nodules into (Warren’s 
classification): 
 Hot nodules – hyper functioning 
 Warm nodules – Functioning 
 Cool nodules – Hypo functioning 
 Cold nodules – Non functioning 
 This classification of nodules into four categories has difference of 
opinion. Meadow using this classification found carcinoma in one of the 77 
hot (1-7%), one of 15 warm nodules (6.6%), 2 of 43 cool nodules (4.7%), 
and 14 of 24 cold nodules (58%). 
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 Johnston, Beirwalter grouped cool and cold nodules together and 
found 14 cases of carcinoma in 32 cold nodules, one case of carcinoma in 10 
warm nodules (10%) and no malignancy in hot nodules.  Slatter and 
Pelnutter mentioned only two types of nodules, Hot and cold. 
Pathogenesis of thyroid nodules 
 Thyroid nodules whether toxic, simple or malignant seem to arise as a 
result of thyroid follicles losing their dependence of thyroid stimulating 
hormone, a breakdown in the serve mechanism (Selwyn Taylor 1969). 
Selwyn Taylor suggested that the nodules in the nontoxic goitre are initially 
little foci of hyperthyroidism. He traced the origin of thyroid nodules back to 
the stage of simple hyperplasia. It is at this stage that the goitre is 
preventable. 
Auto radiographic studies 
 This method of study consists of a slice of the thyroid gland exposed 
to a photographic film, which becomes black when the tissue contains 
radioactive material. Thus it makes possible for comparison of any area of 
thyroid with its capacity to concentrate and bind iodine to protein, in other 
words to synthesize thyroid hormones. By this study the evolution of the 
nodular goitre is divided into five stages (Selwyn Taylor Hypothesis). 
 
  
132 
 
Stage 1: The diffuse enlargement of thyroid gland, which shows increased 
vascularity a large uptake of radioiodine and with uniform blackening of 
auto radiograph. This is typical of puberty goitre but many persist for years. 
Stage 2: Discrete focal areas of hyperplasia with corresponding blackening 
of autoradiograph. There are very few patients in whom all the functioning 
thyroid tissue is concentrated in a single area. Rawson described this very 
aptly as a toxic nodule in a nontoxic gland. Patient presents with erythroid 
state in this stage. 
Stage 3: Lobules become increasingly hyperplastic and vascular. This stage 
is typified by disruption and haemorrhage. The blood supply in the nodules 
is carried by this walled tortuous dilated vessels, which bleed easily 
producing haemorrhagic necrosis by compression of surrounding tissue, 
fibrous pseudo capsule is formed around part of the nodule with obliteration 
of small vessel and formation of Arteriovenous shunt. These perinodular 
shunts also adversely affect blood supply of nodule. Therefore, bleeding and 
necrosis in the nodule is common. 
Stage 4: Nodules undergo resolution in one or two ways, either a large, lace 
of colloid fills it and this is found to be free of iodine or mass of new 
follicles grow to supercede it and again their colloid does not take up 
radioiodine. 
  
133 
 
Stage 5: The Multinodular goitre is brought about by continued repetition of 
the process described above, with the result that most of nodules are inactive 
and incapable to metabolize iodine but among them are few active foci, 
which are currently supplying normal body requirement. In the hypothesis of 
Selwyn Taylor, the functioning nodule was a stage in the evolution of all 
nodular goitre is questioned by Scintiscan studies to determine the function 
of solitary or dominant thyroid nodule. It has been demonstrated in 
autonomous micro or macro nodules in the same thyroid gland suggesting 
that small nodules function in this manner form their origin. Auto 
radiographic studies with gross autonomous functioning nodule have 
demonstrated similar functioning micronodules. 
 Transition from functioning to non functioning nodule may occur 
through degenerative change or possibly by simple loss of functional 
capacity of follicles. Autonomous micronodules from the very early stage 
suggest partial loss of trophic control. The finding of functioning 
micronodule in the same gland with similar macro nodules strongly suggests 
that large nodules were functioning through the period of growth. High 
levels of monoiodotyrosine and diiodotyrosine are found in cold nodules and 
low in hot nodules. 
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Histopathology of Multinodular goitre22, 23, 24 
 The initial stage of nodular goitre is a simple goitre. With the passage 
of time due to repeated involution and hyperplasia, multiple nodules appear 
gradually. These nodules increase with advancing years. The thyroid acini 
are divided into three types depending upon the stage. 
Resting stage: The acini are large, lined by flattened cells and filled with 
dense homogenous colloid. 
Secretory Stage: Acini are lined by cuboidal epithelium and their colloid 
does not stain intensely. 
Response Phase: Acini are lined by columnar cells and contain highly 
stained vacuolated colloid. As the simple goitre changes to nodular goitre the 
histological appearance vary according to the stage. 
Ι. Stage of hyperplasia 
 It is due to increased TSH, which is secreted in response to low levels 
of circulating thyroid hormones. 
Histology 
 Here the acini are hyperplastic and distorted by ingrowths and 
invagination of epithelium. The acini are lined by tall columnar cells. The 
colloid is less in amount. This phase will slowly change into colloid goitre. 
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II. Colloid Phase 
 It cannot be differentiated from hyperplastic gland clinically 
Histology 
 Here the gland is a mixture of hyperplasia with colloid acini. The acini 
are lined by cuboidal cells. The concentration of iodine is less than normal 
gland. When the supply of iodine increases, the gland undergoes involution. 
Both hyperplastic and colloid goitre are associated with euthyroidism. 
III. Nodular Phase 
 It is an irreversible stage of a simple goitre and is due to repeated 
stimulation of the gland. The process of hypertrophy, hyperplasia and 
involution follow repeatedly. Faulty areas of involution associated with 
colloid distension will compress the normal glandular tissue. This with 
newly formed fibrous tissue causes the nodule to become encapsulated. 
Macroscopically the nodules may be single or multiple. The nodules may be 
pale yellow pink and opaque in appearance. Dissolution of follicle lead to 
cyst formation and cyst may contain cholesterol crystals and colloid 
material. 
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Histology 
 Microscopically nodular goitre appears as colloid goitre. It consists of 
poorly  defined fibrous capsule containing colloid filled acini, which are 
lined by low cuboidal epithelial cells. 
Retrosternal goitre 
 Most retrosternal goitres arise from lower pole of a nodular goitre. 
Very few retrosternal goitre arise from ectopic thyroid tissue. If the neck is 
short and pretracheal muscles are strong in men, negative intrathoracic 
pressure tends to draw these nodules into superior mediastinum. Retrosternal 
goitre is often symptomless and is discovered on a routine chest radiograph. 
It receives its blood supply from inferior thyroid vessels.  
Retrosternal goitre may be: 
1. Substernal – commonest type, lower border of thyroid is behind the 
sternum. 
2. Intrathoracic – No thyroid is seen in the neck. Diagnosis is by 
radioiodine scan. 
3. Plunging type – when intrathoracic pressure raises as when the patient 
coughs, lower border is seen in the neck. 
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Retrosternal goitre however can cause severe symptoms. 
 Dyspnoea – particularly at night with cough and stridor, due to 
pressure on trachea. 
 Dysphagia – due to pressure on oesophagus.  
 Pressure on great veins at thoracic inlet gives rise to enlargement of 
veins on neck and front of chest. 
 In severe cases there may be obstruction of superior venacava. 
 Retrosternal goitre may be toxic or malignant. A chest radiograph in 
case of retrosternal goitre shows widened soft tissue shadow in 
superior mediastinum sometimes with calcification and often causing 
deviation and compression of trachea. 
COMPLICATIONS OF MNG 
The complications of MNG are as follows: 
1. Secondary thyrotoxicosis 25 
 Its incidence is difficult to estimate but figures as high as 30% are 
reported.21 In many cases of toxic nodular goitre the nodules are inactive 
and it is the internodular tissue that is over active and is due to a family of 
IgG immunoglobulins which bind with TSH receptor sites (TRABS) and 
activates TSH receptors on follicular cell membrane. They have a more 
protracted action than TSH (16-24 hours versus 1.5 to 3 hours). 
  
138 
 
 However in some toxic nodular goitre one or more nodules are 
overactive and here the hyperthyroidism is due to autonomous thyroid tissue 
as in toxic adenoma and is termed as plummer’s disease. 
2. Tracheal compression 
 It may be due to gross displacement of trachea in lateral or 
anteroposterior plane. It is commonly due to haemorrhage into a nodule and 
in retrosternal goitre. 
3. Malignant change 26, 27 
 It is one of the most controversial subjects which are still not settled. It 
is an uncommon complication. The incidence of carcinoma in MNG has 
been reported as 5-10%.7  In this view Sokal has reported that 4% to 17% of 
nodular goitre develops thyroid cancer26, 27. The malignancy is usually of 
follicular type. 
APPROACH TO MULTINODULAR GOITRE 28,29, 
 The thyroid nodule may be palpable or hidden and symptomatic or 
asymptomatic. The thyroid nodules of less than 1-2 cms are not palpable. 
The gland may be normal or abnormal in structure and function. 
Case history 
 The symptoms are important evidence to know whether hyper or 
hypo-thyroidism is associated with goitre. The patient and family members 
  
139 
 
may have noticed alteration in mental activity irritability or excitability. The 
patient may give history regarding alteration in temperature tolerance, 
perspiration and change in weight, bowel habits and appetite or eye changes 
or palpitation. Pressure symptoms like dysphagia, hoarseness of voice, or 
dyspnoea may occur with goitre. A history regarding diet, ingestion or 
goitrogenic foods like cabbage, soyabeans and drugs should be elicited. 
History of having stayed in endemic area and family history of similar 
swelling should be recorded 
General physical examination 30 
 Here the signs of hyper or hypothyroidism are to be recorded. 
Tachycardia during sleep and loss of weight in hyperthyroidism, whereas 
bradycardia and weight gain are seen in hypothyroidism. The extremities 
will be hot and moist in hyperthyroidism and cold and dry in 
hypothyroidism. Tremors of hand and tongue are seen in hyperthyroidism. 
 Eye signs are characteristic of primary thyrotoxicosis and these 
include Stelwag’s sign, Van Graef’s sign, Joffroy’s sign and Moebius sign. 
In secondary thyrotoxicosis the eye signs are not the characteristic feature.26 
Local examination Inspection It is the most important part of examination. It 
provides lot of information and thyroid gland is confirmed by movement 
with deglution. To know the retrosternal extension of the goitre, one must 
look for the lower border of the gland. palpation the gland is palpated both 
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from behind and in front of the patient, for better palpation of localized 
nodules. During palpation consistency and type of enlargement of the gland 
is noted. The surface is bosselated with gross varying of consistency in 
MNG, where as in thyroid carcinoma the consistency is hard, with indistinct 
margin and irregular surface. If lower border of the gland is not felt, it 
suggests retrosternal goitre. Examination of regional lymph nodes, carotid 
pulsation and position of trachea must be done routinely. 
INVESTIGATIONS FOR MNG 
Diagnostic tests of thyroid function and structure 
 Now-a-days varieties of tests that provide objective evidence of the 
status of thyroid function and to assess the thyroid lesions are increasing 
constantly. No single test or procedure consistently yields a reliable result for 
diagnosis, but each test has a specific indication. Most frequently the results 
of tests combine to provide a correct overall assessment of thyroid function 
and structure. 
I. Tests for thyroid function 
1. Thyroid hormones (T4 and T3) assay 
2. Tests of thyroid binding proteins 
3. Free thyroid hormone indices 
4. Free thyroid hormone measurements (FT4 and FT3). 
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5. Pituitary thyroid axis (TSH) assay 
6. Hypothalamic – pituitary axis (TRH test) 
II. Dynamic and Imaging studies of the Thyroid 
1. Radioactive iodine uptake (RAIU) study 
 TSH stimulation test 
 T3 Supression test 
 Perchlorate discharge test 
2. Thyroid scintigraphy 
 Routine Scintigraphy 
 Whole body Scintigraphy for thyroid metastasis 
3. Miscellaneous radioisotope imaging tests 
 Gallium/ thallium 
 Other radiopharmaceuticals – DMSA 
III. Assessment of thyroid anatomy 
 Ultrasound scan 
 Fluorescent scanning 
 Computerised tomography (CT) 
 Nuclear magnetic resonance imaging (NMRI). 
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IV. Tissue diagnosis 
 FNAC 
 Core needle biopsy 
V. Measurement of thyroid autoimmunity 
 Anti-thyroglobulin antibodies 
 Antimicrosomal antibodies 
 Long acting thyroid stimulator (LATS) 
 Thyroid stimulating immunoglobulins (TSI) 
VI. Miscellaneous tests 
 X-ray of the neck – AP and lateral vews 
 X-ray of the chest - PA view 
 Indirect laryngoscopy 
 Thyroglobulin assay 
 Calcitonin assay 
Hormonal Assay 
Total thyroid hormones 31 
 Total T4 and T3 are measured by specific radioimmunoassay. Since 
they are highly protein bound, their values depends on the levels of the 
binding proteins in the serum. Most patients with hyperthyroidism with 
normal levels of protein have high T4 and T3 less commonly only T3 is high 
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(T3 toxicosis) and this is more characteristic of hyperthyroidism due to a 
functioning autonomous nodule, early Grave’s disease or those replacing 
after stopping anti-thyroid drugs. The normal total plasma T4 level is 
approximately 8 micro g/dl and plasma total T3 level is 0.15micro g/dl.32 
Causes of high level of thyroid hormones 
• Hyperthyroidism 
• Increased binding proteins 
  Pregnancy 
  Oral contraceptive 
  Active hepatitis 
  Hereditary 
  Porphyria 
  New born 
  
 Antibody to thyroid hormones 
 Pituitary resistance to thyroid hormones 
Causes of low levels of thyroid hormones (total) 
• Hypothyroidism 
• Decreased binding proteins 
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  Androgens 
  Nephrotic syndrome 
  Hereditary  
  Glucocorticoids 
  Cirrhosis of liver 
  Low T3 syndrome 
  Low T3 and low T4 (sick euthyroid) 
Tests of thyroxine binding proteins 
 For estimation of TBG and TBPA there are specific 
radioimmunoassay tests. Because TBG is the most important protein, 
carrying 70-80% of the hormone, it is usually measured alone. 
 Thyroxine binding capacity (TBC) can be measured indirectly by 
quantitating the capacity of binding sites in serum, which are not carrying 
hormone. This is done using the T3 resin uptake test (T3RU) and usually it is 
in the range of 25% to 35%. If there are a lot of unoccupied binding sites on 
the proteins, the racer will bind there and the T3RU is low and vice versa. 
Knowledge of T4, T3 and T3RU values makes it possible to determine if the 
problem is due to thyroid diseases, or to a binding protein abnormality. If 
both the tests are abnormal in the same direction, the thyroid is at fault, Eg. 
If T4 and T3RU are both high, hyperthyroidism is diagnosed. In contrast if 
one test is high and the other low, the defect is due to carrier proteins. 
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Free thyroid hormone indices (by calculation) 
This is obtained by the formula: 
FT4 I= (Total T4) (T3RU)/100 
FT3 I= (Total T3) (T3RU)/100 
 These tests have gained widespread acceptance in practice because the 
two tests used for its derivation are simple and are robust. 
Free thyroid hormone (FT4) measurement 
 FT4 can be measured by two methods, Equilibrium dialysis or 
radioimmunoassay. It is generally accepted that the dialysis method is the 
gold standard, however it is restricted to research laboratories. 
 Radioimmunoassay is sensitive and specific. FT4 measurement 
provides excellent index of thyroid status in almost any clinical situation 
with the few exceptions, which are very rare. E.g. Heparinized patients and 
in acute psychiatric illness. This test is not influenced by abnormalities in the 
thyroid binding proteins. 
Pituitary Thyroid axis – TSH 
 TSH radioimmunoassay became available in 1965. When TSH is 
above normal and T4 and T3 are normal, it is called subclinical 
hypothyroidism. But older assay could only differentiate TSH levels of 1 
µu/ml or 2 µu/ml and since many euthyroid individuals have TSH levels of 
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0.5µu/ml to 2.0 µu/ml, assay could not separate suppressed values from 
normal values, but with the introduction of immunoradiometric assay 
(IRMA) and amplified enzyme linked immunoassay (AEIA), TSH levels less 
than 0.3 micro units/ml can be detected. TSH is an extremely valuable 
diagnostic aid, hypothyroid patients have high levels and hyperthyroids have 
low levels, provided pituitary insufficiency is excluded. When thyroid 
hormones are at normal level and TSH in undetectable it is called subclinical 
hyperthyroidism. 
Hypothalamic pituitary axis (TRH Test) 
 This is tested by injecting TRH intravenously and evaluating the 
response of the pituitary to secrete TSH. A normal response is a rise in TSH, 
which is maximal at 20-30 minutes with return to normal by 60-90 minutes. 
In hyperthyroidism the pituitary is suppressed by thyroid hormone and there 
is no rise in TSH after injection of TRH. 
 This test was of great value in understanding the physiology and 
pathophysiology of the hypothalamic pituitary thyroid interaction and it was 
valuable clinically in the diagnosis of borderline hyperthyroidism. Because 
of the development of sensitive TSH measurement, which shows suppressed 
levels in hyperthyroidism the TRH test is superfluous in this role. Patients 
with primary hypothyroidism have an elevated TSH by definition; therefore 
TRH test is also superfluous in this situation. 
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Thyroid Antibodies31:- 
If serum thyrotropin level is elevated, serum antithyroglobulin or 
antithyroperoxidase antibody assay is useful for diagnosis of Hashimoto's 
thyroidits. However, the finding of an elevated level does not obviate the 
need of FNAC, to rule out a coexisting cancer including lymphoma. 
FINE NEEDLE ASPIRATION CYTOLOGY (FNAC)33,34,35,36 : 
 FNAC has become established as the choice of investigation in thyroid 
swellings. It has excellent patient compliance, is simple and quick to perform 
in outpatient department and is readily repeated. 
Procedure 30: It is carried out with the patient in supine position with a 
pillow placed under the shoulders and neck well extended. It is performed 
with a 10 cc or 20 cc syringe coupled with a fine 22, 23 or 25 gauge needles. 
The nodule is secured firmly between fingers, and while suction is applied, 
2-6 passes are made into the nodule. 
 Suction is released before exiting the nodule or as soon as material 
appears at the hub of needle. If the sample enters the syringe, part or the 
entire specimen may be lost in the syringe. This technique, although simple 
to perform, is subject to the operator's experience. It is dependent on the 
placement of the needle, the sensitivity of the finger tips and the amount of 
suction applied. Recently, a technique of needle aspiration without suction 
i.e. fine needle non aspiration cytology (FNAC) is advocated to reduce 
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traumatic blood aspiration and has been particularly useful in smaller 
nodules37. This technique uses the needle for cutting and the capillary 
pressure of tissue for sampling. Air-dried smears and wet smears are 
obtained concurrently. Airdried smears include the Diff-Quick and the May-
Grunwald-Giemsa methods. After carefully expelling the sample on a glass 
slide, the aspirate is allowed to air dry. The air-dried smear highlights the 
background colloid, the cell architecture, and the cytoplasmic details. This 
technique is helpful for the diagnosis of medullary and lymphoid tumors. 
The Papanicolaou stain is a wet smear that requires immediate fixation with 
95% alcohol. This method enhances nuclear morphology such as grooving 
and inclusions, and is better suited for detecting papillary carcinoma. An 
adequate smear consists of at least 5-6 groups of follicular cells, with each 
group containing at least 10 cells. The aspirate content can be spinned down 
in the laboratory and cells that have precipitated can be processed as a larger 
tissue sample (cell block). Cell block processing has the potential of 
increasing accuracy of FNAC, particularly for FNAC that is labeled as 
“suspicious “. 
 Ancillary tests to improve the accuracy of FNAC include 
immunohistochemistry , ploidy studies, molecular markers and more 
recently, Reverse Transcription-Polymerase Chain Reaction (RT-PCR.), to 
detect thyroglobulin mRNA and thyrotropin- receptor mRNA. This RT-PCR 
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technique is most useful when an FNAC is obtained from an adjacent lymph 
node 38.  
Complications from FNAC are neither significant nor frequent. 
Cytological and histological features of different thyroid disorders 23 
1. Normal thyroid: 
 Small clusters and sheets of epithelial cells with small amount of thin 
colloid, C cells, cartilage, tracheal epithelium and skeletal muscle may be 
found. 
2. Nodular colloid goiter: 
Diagnostic criteria are as follows: 
  Abundant colloid of both thick and thin types 
  Follicular cells in sheets and clumps, fragile feathery cytoplasm, 
numerous bare nuclei 
  Foamy cells 
  Degenerating erythrocytes 
  Hyalinized stroma 
3. Grave’s disease: (Primary hyperplasia) 
  Blood stained smear with little colloid 
  Moderate amount of epithelium and some follicular and ring 
structures 
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  Enlarged cells with more abundant vacuolated cytoplasm, variation in 
nuclear size 
  Fire flares/ colloid suds/ marginal vacuoles are the features in this       
disorder 
4. Hashimoto’s thyroiditis: 
  Presence of Ashkenazy 
  Moderate number of lymphocytes mainly of small mature type and 
scattered plasma cells 
  Small multinucleate giant cells, epitheloid histiocytes. 
  Thyroid follicles disrupted and the follicular basement membrane is 
 damaged with enlarged epithelial cells with characteristic oxyphilic 
change in the cytoplasm 
5. Mulitnodular goiter: 
 Microscopically there will be normal to hyperplastic foci of thyroid 
tissue, large areas of colloid, hemorrhage, fibrosis and calcification, variable 
amounts of lymphocytic infiltration can also be seen. 
6. Follicular adenoma: 
 These are 3 types, according to their architecture, cellularity and 
amount of colloid. They are fetal colloid, embyonal and Hurthle cell types. 
Hurthle cell lesions contain cells that are markedly eosinophilic and whose 
cytoplasm contains abundant mitochondria. 
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7. Follicular carcinoma: 
 These may be non invasive (minimally invasive) or invasive (angio 
and capsular invasion). In few cases Hurthle cells are present which show 
aggressiveness of the tumour. 
8. Papillary carcinoma: 
 Presence of colloid filled follicles with papillary projections. In some 
cases calcified lesions are found which are called Psamomma bodies, which 
is diagnostic feature of papillary carcinoma. In few cases, presence of orphan 
eyed nuclei Annei with a pale empty nuclei may be seen. 
9. Medullary carcinoma: 
 Dispersed cell pattern, cuboidal cells with oval, eccentric pleomorphic 
nuclei and well defined gray blue cytoplasm, spindle cell forms with 
elongated cytoplasm, red cytoplasmic granularity and presence of amyloid 
material in the background are the characteristic features. 
10. Anaplastic carcinoma: 
 Bizarre, large malignant cells with macrophage like appearance, 
multinucleate malignant cells, and malignant spindled cells with 
mesenchymal appearance and necrotic cell fragment debris with a dirty 
background are the features. 
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11. Lymphomas: 
 Shows mixed cell population resembling reactive processes like 
elsewhere in the body. 
HISTOLOGICAL FEATURES OF DIFFERENT THYROID 
DISEASES: 
  
   Slide 1: Colloid goiter                              Slide 2: Hashimotos thyroiditis 
 
    Slide 3: Follicular adenoma                      Slide 4: Follicular carcinoma 
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     Slide 5: Papillary carcinoma                  Slide 6: Anaplastic carcinoma 
                              
                                         Slide 7: Medullary carcinoma 
Complications of FNAC 
Pain Fibrosis 
Formation of calcification Cystic degeneration 
Hematoma Transient thyrotoxicosis 
Necrosis of nodule Transient bradycardia 
Entry into trachea Elevation of thyroglobulin level 
Capsular pseudo invasion Transient vocal cord paralysis 
Transient thyroid swelling  
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 Accurate diagnosis can be made in colloid nodules and inflammatory 
thyroid disease. (Hashimoto's thyroiditis, De Quervain's thyroiditis and 
tuberculosis). Papillary, medullary, anaplastic cancers and thyroid 
lymphomas are diagnosed with ease. But diagnosis of follicular cancers is 
virtually impossible30. If the cytology is bizarre, medullary cancer must be 
excluded by staining for calcitonin and serum calcitonin analysis 22. 
 After FNAC, the majority of nodules can be categorized into 
following groups 37, 38, 39. 
 Benign (65%) 
 Indeterminate or suspicious for follicular cell neoplasm (20%) 
 Malignant (5%) 
 Non diagnostic (10%) 
 FNAC has sensitivity of 83% and specificity of 92%. The incidence of 
false positive results is approximately 1% and false negative results occur in 
approximately 3% of patients 32. 
 Benign lesions include cysts and colloid nodules.The risk of 
malignancy in this setting is less than 3% 3 
 The risk of malignancy in the setting of suspicious cytology is 
anywhere from 10 to 20%. Most of these lesions are follicular or Hurthle cell 
neoplasm. In this situation, diagnosis of malignancy relies on demonstrating 
capsular or vascular invasion, features that cannot be determined via FNAC. 
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 There is a little or no value in repeating FNAC for a follicular or 
Hurthle cell lesion. However, no effective method has been found to identify 
malignant lesions that yield indeterminate cytologic result upon FNAC, 
except for some promise about using immunohistochemistry methods for 
follicular neoplasm. So, it is best to treat all suspicious cytology 
surgically.37,38 
RADIOGRAPHY:  
 Chest and thoracic inlet radiographs are only necessary when there is 
clinical evidence of tracheal deviation or compression or retrosternal 
extension.  This is helpful to diagnose the position of the trachea whether 
displaced or narrowed. Straight X- ray is also helpful in diagnosing 
retrosternal goitre40  
ULTRASOUND:  
 It has a value to differentiate between solid and cystic swellings. It 
also demonstrates clinically impalpable nodules and Lymph Nodes. But its 
value to diagnose malignancy is limited. 
 Sonography demonstrates in some patients that a single, clinically 
palpable nodule is one of many sonographically visible nodules is of the 
most likely diagnosis in Multinodular Goitre. The clinical differentiation is 
important since the risk of cancer is less in Multinodular Goitre.36 Recent 
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data suggest that 50% of patients with a single nodule have other nodule 
demonstrated by careful USG. 41 
CT AND MRI:  
 These newer methods have not yet proved themselves very helpful in 
detecting day- to- day thyroid disorders. These are still in the experimental 
stage. 40 
THYROID AUTO- ANTIBODIES:  
 Serum titres of antibodies against thyroid peroxidase and 
thyroglobulin are useful in determining the cause of thyroid dysfunction and 
swellings. Autoimmune thyro iditis may be associated with thyroid toxicity, 
failure or euthyroid goitre. Titres of greater than 1:100 are considered 
significant but a proportion of patients with histological evidence of 
lymphocytic (auto immune) thyroiditis is seronegative.  
INDIRECT LARYNGOSCOPY:   
 To determine the mobility of the vocal cords is widely used 
preoperatively, although usually for medicolegal rather than clinical reasons. 
To see the condition of the vocal cords to exclude injury to the Recurrent 
Laryngeal Nerve during operation. So laryngoscopy should also be 
performed just after operation. Only in 3% of cases there may be 
symptomless cord paralysis. These cases are to be segregated from cord 
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paralysis due to Recurrent Laryngeal Nerve injury during operation by 
Laryngoscopy preoperatively.42 
CORE NEEDLE BIOPSY:  
 This is done under local anaesthesia is occasionally of value in 
establishing diagnosis in patients with a large often hard and fixed mass in 
the neck frequently on the basis of anaplastic carcinoma or t hyroid 
lymphoma. Core biopsy produces a small cylinder of tissue which is 
subjected to histopathological examination because of the caliber of the 
needle and the consequent hemorrhage, haematoma, perforation of Trachea 
and damage to Recurrent Laryngeal Nerve.43 
TREATMENT  
There are three main approaches to the treatment of this condition.  
1. MEDICAL  
2. RADIOIODINE 
3. SURGERY  
 Non specific measures such as rest, sedation and ß adrenergic blockers 
are helpful to treat this condition.  Indications for therapy in patients with 
multinodular goitre including hyperthyroidism.  
1. Compression symptoms attributed to the goiter.  
2. Cosmetic concerns of patient.  
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4. Concern about malignancy based on the history, examination and fine 
needle aspiration cytology.  
5. Recent growth.  
MEDICAL TREATMENT  
Levothyroxine suppression therapy:  
 The use of thyroid hormone in suppression of multinodular goitre is 
controversial. Thyroid hormone prescribed in an attempt to reverse or 
prevent thyroid growth by suppressing TSH's direct thyrotrophic effect and 
any indirect permissive effect on other growth factors such as epidermal 
growth factor. The goal of suppression therapy is a serum TSH level in the 
low normal range. Further TSH suppression is not recommended, in order to 
avoid possible untoward side effects of subclinical hyperthyroidism. A 
modest dose of levothyroxine (100 mcg) is usually adequate, but monitoring 
of the serum TSH is recommended to determine dosage adequacy. Both 
levothyroxine and levotriiodothyronine are equally effective in suppressing 
TSH levels but the former is preferred because of its much longer half life, 
which renders it potentially less toxic and aids in ease of patient use. Patient 
compliance with therapy is important, because multinodular goitre growth 
resumes if treatment is interrupted or discontinued. 44 
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 Potential disadvantages of thyroid hormone suppression therapy in 
patients with multinodular goitre, in addition to its debated efficacy, include 
subclinical or frank hyperthyroidism with the potential for bone loss and 
card iac dysrhythmias. Indeed, subclinical hyperthyroidism from functional 
autonomy of the nodular goitre, defined as blunted TSH response to TRH 
stimulation, is present in upto 27% of clinically euthyroid patients with 
multinodular goitre. There is no study in which normalization of the thyroid 
volume and disappearance of nodules is documented convincingly. Thus 
hormonal suppressive treatment cannot be accepted as a reasonable long 
term treatment for euthyroid nodular disease.45 
 Antithyroid drug therapy: The reported success of long- term 
antithyroid drug use in the treatment of toxic multinodular goitre is 
extremely poor. Of the 41 patients studied by Van Soestbergen and 
colleagues41/39(95 %) developed recurrent hyperthyroidism following 
cessation of antithyroid drug therapy. The mean time of relapse was 5.2 
months with 95 percent relapse occurring within the first year. Because 
prolonged antithyroid drug therapy in patients with toxic multinodular goitre 
seldom results in permanent remission and recommended only as adjunctive 
therapy when needed for the initial control of hyperthyroidism. The 
preponderance of the evidence suggests that it is not helpful to use combined 
antithyroid drug- thyroxine therapy to enhance the chance of remission.  46  
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Radioiodine therapy and toxic multinodular goitre  
 The clinical utility of radioiodine therapy in the management of toxic 
multinodular goitre is well established. So as not to skew the results of 
reported successful radioactive iodine therapy in patients with toxic 
multinodular goitre, however, one must be careful to separate patients with 
multinodular goitre from patients with diffuse goitre5, Graves' disease, and 
single toxic adenoma. In addition, thyroid size and nodularity are assessed 
only by palpation in many s tudies, and others do not clearly define the 
duration of follow up in assessing response to radioactive iodine therapy. 
Nevertheless, a large number of patients with toxic multinodular goitre 
eventually achieved a 92 per cent euthyroid success rate following treatment 
with modest doses of radioactive iodine (25 milli Curies of I131 of less); 
others have reported similar (70 percent to 88 percent) results.45  
 In patients with toxic multinodular goitre studied by Jensen and 
colleagues (estimated average gland weight by palpation 61 g), the mean 
radioactive iodine treatment dose was 37 mCi of I131, which yielded a 57 
percent probability that the patients would become euthyroid after one year. 
Twent y- five per cent of these patients required a second radioactive iodine 
treatment within the first year for persistent hyper- thyroidism. A statistically 
significant association was not seen between successful treatment of 
hyperthyroidism and estimated gland size or radioactive iodine dose 
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administered per gram tissue. Although some authors report only a 3 per cent 
to 7 per cent persistence rate for hyperthyroidism when a much large 
radioactive iodine dose is used, this has not been observed by others. Thus in 
treating patients with a large toxic multinodular goitre surge ry is preferred 
over radioactive iodine therapy, because of the more rapid resolution of 
hyperthyroidism.45  
 The actual overall incidence of hypothyroidism following radioactive 
iodine therapy is low (3 per cent to 9 per cent) in studies exclusive of single 
nodule and diffuse goitre. Life table method of calculating hypothyroidism 
after RI therapy in toxic multinodular goitre is more variable, yielding rates 
of 6% to 64%. It appears that the development of hypothyroidism is variable 
and likely reflects the early post- radioactive iodine success in treating toxic 
multinodular goitre.  
 Plummer’s disease as drug uptake is variable, there is minimal impact 
on the size of the gland and response is slow. Surgery is best carried out 
sooner rather than late to avoid compromise of the airway and the 
cardiovascular system..47  
 Day TA, CHU A. Hoang KG In studies shows a thyrotoxicosis is often 
present in patients with long studying in multi nodular goiter, although the 
slow changes in thyroid functions may not have been noticed by the 
individual toxic and non toxic multinodular goiter should be addressed 
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separately and the type of treatment should be directed at each of these types 
of multinodular goiter as well as the issues related to the success of each 
treatment options.(48) 
Alcohol sclerotherapy:  
 In use for the last few years mainly in Italian centers in solitary hot or 
toxic nodules and solitary cyst, alcohol sclerotherapy could theoretically be 
used in Multinodular Goitre. The drawbacks are related to pain risk of 
Recurrent Laryngeal Nerve damage and the possibility of extrathyroidal 
fibrosis complicating subsequent surgery.  
Radioiodine therapy and nontoxic multinodular goitre  
 Surgical excision is preferred in patients with nontoxic multinodular 
goitre when treatment is necessary to address compression symptoms or 
cosmetic concerns. If, however, the surgical risk, is high or if patient refuses 
surgery, radioactive iodine therapy is a reasonable alternative. In two studies 
using RI to treat multinodular goitre causing compression symptoms, median 
reduction in thyroid volume was 40% and 60% after one year and two years, 
respectively. As with radioactive iodine treatment of toxic multinodular 
goitre, there is no relationship between initial goitre size and thyroid volume 
reduction. Although it is not uncommon to see an initial increase in thyroid 
volume at one month after radioactive iodine therapy, treatment does not 
aggravate obstructive symptoms.  (48) 
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 In the past, radioactive iodine therapy for multinodular goitre was 
almost universally reserved for elderly patients who were poor surgical risks. 
Because radiation induced carcinogenesis is a late effect, the risk of 
radioactive iodine, inducing cancer in the elderly population is small. No 
data, however, exists for the incidence of radioactive iodine - induced 
malignancy in the treatment of multinodular goitre at any age. The effect of 
high dose of radioactive iodine administration in patients with multinodular 
goitre is not comparable to that in patients treated after thyroidectomy for 
thyroid cancer, because of the difference in extrathyroidal radioactive iodine 
exposure between the two groups. For treatment of large multinodular 
goitres, dosimetry determination of radioactive iodine dose may be 
potentially helpful in ensuring initial therapeutic success and in preventing a 
blood dose no more than 200 rad (2Gy). 
SURGERY: 
Argument for routine removal of nodular goiter : 
 This subject supports the view that the incidence of malignancy 
among the non-toxic MNG is quite high and the most or all such goiter 
should be removed as soon as they are detected, because of the risk of 
cancer. It has been claimed that many lives could be saved by systematic 
search for the removal of nodular goiters based on the following 
consideration. 
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 Many surgical centres throughout the world have statistics, indicating 
that 4-17% of all non-toxic goiter removed were malignant. 
 Even though nodular goiter may be benign at the time of detection, it 
is likely to become malignant later and sho uld therefore be removed as 
cancer prophylaxis. Lahey stated that prophylaxis removal of all discrete 
nodules would do much to lower, if not abolish the occurrence of thyroid 
cancer. This history of pre-existing nodular goiter often of long duration was 
e licited in many series of thyroid cancer. Some authors cited the individual 
history of patient with quiescent benign nodular goiter, which began to grow 
rapidly, and proved to be thyroid carcinoma. Sokal states (49) that some 
nodules might be malignant from the start for which series of 
histopathological studies during every stage of evolution of the goiter may 
be helpful to come near to conclusion and to find out that the 
histopathological abnormality is the earlier stages to predict malignancy 
later. (50) 
 Vini L and associates reported that differentiated thyroid cancer found 
incidentally at surgery for hyperthyroidism has a good prognosis. 
Argument against removal of nodular goitre : 
 The selection of statistics from the centre is highly selective and is not 
representative of population in general 
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 Nodular goitre is quite common in endemic areas but the thyroid 
cancer is rare. 
 Clinically correct diagnosis may be made between benign and 
possibly malignant swellings. 
 Benign goiters rarely undergo malignant transformation and there is 
no assurance that surgery will prevent the thyroid cancer. 
MANAGEMENT OF CASE OF MULTINODULAR GOITRE
 
SURGERY OF THE THYROID GLAND: 
suspicious/maligant
NON-TOXIC 
normal tsh
MNG
surgeryI 131 
Toxic
tsh/t3/t4
LT4
FNAC
surgery
benign
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 Bliss R stated that surgery in elderly patients is as safe as in younger 
patients with no increase in morbidity. Benign MNG is the most common 
indication for surgery. (51) 
Following are the operations done in non-toxic and toxic MNG : 
 Management of patients with MNG band on thyroid function (serum 
TSH, T4/T4) and thyroid fine needle aspiration cytology. 
I) Subtotal Thyroidectomy : 
 It is a standard operation undertaken for toxic MNG. Approximately 
7/8th hyperplastic gland is removed retaining the posterior margin in order to 
maintain a euthyroid level and to protect the parathyroid gland the recurrent 
laryngeal nerve. 
 The care of non-toxic goiter, it is advisable to leave an amount equal 
to a normal gland. Only the enlarged amount is resected. 
Contraindication: Subtotal thyroidectomy is contraindicated in persons 
with thyrotoxic congestive cardiac failure. Particularly when cardiac reserve 
is low and the goiter is small and adherent such patients are recommended 
radioiodine therapy. It is also contraindicated in ophthalmoplegia, for rapid 
reduction of the toxic stage may worsen the eye condition and at least 6 
months control by anti – thyroid drugs such as carbimazole should be under 
taken before subtotal thyroidectomy can be safely performed. 
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II) Near total thyroidectomy . Total Thyroidectomy : 
 The reported incidence of nodular recurrence following subtotal 
thyroidectomy for MNG range from uncommon is 10%. Kraimp and 
colleagues reported that following subtotal thyroidectomy recurrent 
nodularity developed in 25 to 735 (3.4%) patients with MNG. 25% of 
nodular recurrences occurred in each follow up period of 0-5 years and 5-10 
years. 50% of patients with recurrence had so more than 10 years after 
surgery. Immediately post operative thyroid hormone therapy may have 
delayed, but did not prevent recurrence and once post operative nodule 
recurrence was documented thyroid hormone treatment did not inhibit 
further growth.(52) 
 Most likely the best prevention of recurrent post operative MNG is 
near total thyroidectomy. The experience hands complications of total 
thyroidectomy are no different from those of subtotal thyroidectomy. (53) 
Operation Steps in Surgery : 
 Preparation of the patient – the fitness for the surgery is decided by the 
status of the hemoglobin, cardiovascular condition, respiratory system as 
usual oral hygiene is improved to avoid post operative respiratory 
complications. When the patient is toxic, the toxicity must be brought down 
to the euthyroid state before surgery either by sedation alone or in 
combinations with anti – thyroid drugs carbimazole 30-40 mg/day in divided 
  
168 
 
doses until toxicity comes down and followed by 5mg every 8t h hourly as 
maintenance does. The response to the treatment is assessed by subjective 
improvement of the symptoms, slowing of the pulse rate and thyroid profile 
tests. Iodides alone are not advocated but some prefer to add Lugol’s to 
carbimazole 10days prior to surgery. Propranolol may be used along with 
carbimazole in the management of very severe toxicity and to reduce the 
length of pre operative preparation. 
SUBTOTAL THYROIDECTOMY : 
Skin Incision and Raising the Flaps 
 The skin incision can be marked by pressing a length of thread on to 
the skin before using the scalpel keeping in the of skin crease 2-3cms above 
the sternum. The collar (Kocher’s) incision is then made, extending to the 
lateral borders of the two sternocleidomastoid muscle. With larger goiters 
the incision is made little higher up. In order to give a neat scar, the platysma 
is divided at a slightly higher level than the skin. The flaps of skin, 
superficial fascia and platysma are divided at a slightly higher level than the 
skin. The flaps of skin, superficial fascia and platysma are then reflected 
upwards to the level of the thyroid cartilage and downwards to the sternum. 
Skin edges are held wide apart. The anterior jugular veins are divided 
between ligatures. 
 
  
169 
 
Exposure of the thyroid gland 
 The investing layer of deep fascia is incised vertically in the midline. 
Any anastomosing veins being secured and the interval between the infra 
thyroid muscle is opened to expose the sheath of pretracheal fascia covering 
the glands if additional exposure is necessary then the infrahyoid muscles are 
sectioned about an inch above the skin incision. The pretracheal fascia is 
now incised and finger is passed over front of each lobe to ascertain its size 
and extent. As a rule, larger lobe is dealt with first and by retraction of the 
infrahyoid muscle and fascial sheath the greater part of its anterior surface is 
exposed. 
Thyroid Dissection: 
 The lateral surface of the lobe is cleared by finger during this 
procedure. Middle thyroid vein if present is divided between ligatures. The 
inferior thyroid vein, which forms a venous plexus anterior to the trachea is 
carefully dissected. The muscles are retracted strongly in an upward and 
lateral direction and the upper pole if the gland is delivered at the wound. 
When the vascular superior thyroid pedicle becomes apparent this is divided 
between ligatures with a double ligatures to the upper stump preferably. A 
finger is swept around the lower pole, which is delivered forwards, after the 
inferior thyroid veins are secured. The lobe is drawn forwards and medially 
and search is made behind it for the inferior thyroid artery. Thus vessel 
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should be ligated well away from the gland in order to prevent injury to the 
recurrent laryngeal nerve. The artery is ligated in continuity. 
Excision of the Gland : 
 After taking the decision about the amount of gland tissue to be left 
behind, several pairs of artery forceps are applied to the capsule of the lobe 
in its postero-lateral aspect along the line of proposed position. The lobe is 
then sectioned from lateral to medial side, in a place towards the front of the 
trachea. 
 The opposite lobe of the gland is then treated in a similar manner, an 
equal amount of the gland tissue being left behind. All hemorrhage points 
being arrested either by fine ligatures or by diathermy coagulation. The 
wound is closed in layers, first the deep cervical fascia, then platysma and 
finally skin. Usually drain is kept deep to the deep cervical fascia. Mattioli 
found that subtotal thyroidectomy is adequate intervention for multinodular 
goiter, as long as the number of clinical recurrence is not significantly high. 
(54) 
TOTAL THYROIDECTOMY: 
 Total follows the technique described above except that the entire 
gland is removed from one tracheoesophageal groove to the other. The 
technique of this procedure is essentially a bilateral version of 
hemithyroidectomy. If it is not possible to preserve parathyroid glands intact, 
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it is preferable to implant them within the sternocleidomastoid muscle rather 
than to remove them completely. Total thyroidectomy may be successful in 
effecting cure of carcinoma, and should be advocated in those cases where 
the growth is sufficiently mobile or if tumour is found in one of the 
lymphnodes outside the thyroid (Hurgreaves, 1981).(55) 
 If the tumour is of papillary type and is confined to one lobe, 
lobectomy with removal of isthmus is usually sufficient.Dissection of lymph 
node only is carried out when they are involved by tumour. The discovery of 
isolated lymph node metastasis from a carcinoma of the thyroid which is 
undetectable clinically (lateral aberrant thyroid) requires total of near total 
thyroidectomy combined with removal of laterally placed nodes especially in 
the younger patients (Frankenthaler 1990).(56) 
 Khadra M and associates stated that in view if the risks of reoperative 
surgery, total thyroidectomy should be considered the operation of choice for 
most benign diseases affecting the whole thyroid gland such as multinodular 
goiter, thyroiditis and goiters affected by thyrotoxicosis.(57) 
NEAR TOTAL THYROIDECTOMY: 
 Surgeons who are uncomfortable performing total thyroidectomy can 
decrease their patients risk of hypoparathyroidism and recurrent laryngeal 
nerve injury by using procedure designed to minimize dissection in the 
contralateral tracheoesophageal groove. Near total thyroidectomy minimizes 
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dissection because it leaves a few grams if thyroid tissue along the posterior 
aspect of the contralateral lobe. If near total thyroidectomy is performed, no  
more than 25% of one lobe (approx 2gm) remains. The surgeon may decide 
to perform a near total thyroidectomy routinely in situations of relative 
indications for total thyroidectomy and possibly in selected situations in 
which precise anatomic dissection is technically difficult. 
TREATMENT OF RETROSTERNAL GOITRE: 
 If obstructive symptoms are present in association with thyrotoxicosis 
it is unwise to treat a retrosternal goitre with antithyroid drugs or radioiodine 
as these may enlarge the goitre. Most common substernal goitres arise from 
the thyroid lobe. (58) 
 Resection can almost always be carried out from the neck and a 
midline sternotomy is hardly ever necessary. The cervical part of the goitre 
should first be mobilized by ligation and division of the superior thyroid 
vessels, and by ligature and division of the middle thyroid veins and the 
inferior thyroid artery. The retrosternal goitre can then be delivered by 
traction and finger mobilization. Haemorrhage is rarely a problem because 
the goitre takes its blood supply with it from the neck. The recurrent 
laryngeal nerve should be identified if possible before delivering the 
retrosternal goiter, as it may be abnormally displaced and particularly 
vulnerable to injury from traction or tearing. If a large multinodular goiter 
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cannot be delivered intact from the retrosternal position it may be broken 
with the fingers and delivered piecemeal, but this should never be done if the 
lesion is solitary and there is the possibility of carcinoma. Armour and 
Colleagues,(59) described morcellement can be a messy process and partial 
claviculectomy offers an easier method while removing difficult retrosternal 
goitre through the standard approach to the thyroid gland. This technique 
was helpful in an obese patient with a large retrosternal extension of the 
goitre. 
TREATMENT OF TOXIC MULTINODULAR GOITRE IN 
PREGNANCY: 
 Thyroid disease during pregnancy is a significant issue, especially 
because the incidence of autoimmune disease of the thyroid approaches 10% 
in women. (60) 
 A retrospective study suggested that the increased prevalence of 
thyroid nodules among women may be related to pregnancy. The prevalence 
of nodular disease is detected by USG, was three times as high in woman 
who had experience at least one pregnancy compared with women who had 
never been pregnant. The evaluation of thyroid nodule discovered during 
pregnancy is similar to that of the non pregnant patient. Nodules with benign 
cytology should be observed and followed by an endocrinologist. If the 
FNAC is consistent with thyroid cancer surgery is recommended. Some 
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experts recommend operating during the 2nd trimester before 24 weeks of 
gestation to minimize the risk of miscarriage. Some experts advocate 
postponing definitive surgery until after delivery in most 
patients.Radioiodine is absolutely contraindicated because of the risk to the 
foetus.(61) 
 The danger of surgery is miscarriage; and that of antithyroid drugs is 
of inducing thyroid insufficiency in the mother, of the baby being born 
goitrous and hypothyroid 
Endoscopic Trans Axillary Thyroidectomy: 
 Under general anaesthesia, patient kept in supine position and arm 
abducted to 90 degrees to the vertical axis of the body to expose the axilla. 
Three 5mm incisions should be made and initial dissection of the working 
space should be accomplished with blunt 3mm Steinman pins beneath the 
platysma and anterior to pectoralis major muscle. Three 5mm trochars 
should be placed through the incisions and directed towards the thyroid 
gland. Insufflations of CO2 at an initial pressure of 7mmHg pressure should 
be used to maintain working space dissection and it should be carried out to 
reach the SCM muscle and thyroid gland. The ipsilateral thyroid lobe should 
be identified and mobilized. After mobilization of the isthmus from the 
anterior surface of the trachea, the gland should be grasped and gently 
retracted anteromedially. This maneuver was facilitated by division of the 
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sternothyroid muscle leaving the more superficial sternohyoid muscle intact. 
This will allow greater anterior retraction, exposing the contralateral inferior 
thyroid pole.  
 Complete dissection of the junction between the thyroid capsule and 
the contralateral inferior thyroid vessels should be accomplished. These 
vessels should be then clipped and divided. Complete mobility of the gland 
should be accomplished, and the contralateral superior thyroid pedicle 
should be exposed. The superior vessels were then clipped and divided, 
freeing the entire gland while protecting the recurrent laryngeal nerve. The 
gland, completely detached, was placed in an Endocatch retrieval bag and 
removed through an extended lateral incision within the axilla. The 
paratracheal spaces were inspected for hemostasis. A 7-mm Blake drain was 
placed within the thyroid bed and anterior chest wall, and brought out 
through one of the 5-mm axillary port sites. 
Postoperative complications  (62), (65) 
Haemorrhage: 
 A tension haematoma deep to the cervical deep fascia is usually due to 
slipping of a ligature on the superior thyroid artery; occasionally 
haemorrhage from a thyroid remnant or a thyroid vein may be responsible. It 
may on rare occasions, be necessary to open the wound in the ward to relieve 
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tension before taking the patient to the theatre to evacuate the haematoma 
and to tie off a bleeding vessel. 
Respiratory obstruction 
 Most cases are due to laryngeal oedema and very rarely due to 
collapse or kinking of the trachea. The most important cause of laryngeal 
oedema is a tension haematoma. However trauma to the larynx by 
anaesthetic and surgical manipulation is an important contributory factor 
particularly if the goitre is very vascular and may cause laryngeal oedema 
without a tension haematoma. Unilateral or bilateral recurrent nerve 
paralysis will not cause immediate postoperative respiratory obstruction. 
Unless laryngeal oedema is also present but they will aggravate the 
obstruction. If releasing the tension haematoma does not immediately relieve 
airway obstruction the tracheal should be intubated at once. An endotracheal 
tube can be left in place for several days; steroids are given to reduce the 
oedema and a tracheostomy is rarely necessary. 
Postoperative thyroid crisis 
 It is an acute exacerbation of hyperthyroidism. It occurs if a thyrotoxic 
patient has been inadequately prepared for thyroidectomy. Very rarely 
thyrotoxic patient presents with a crisis and this may follow an unrelated 
operation. It is characterized by tachycardia, high fever, restlessness and 
delirium, progressing towards cardiac failure. Symptomatic and supportive 
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treatment is for dehydration, hyperpyrexia and restlessness. This requires 
administration of intravenous fluids, cooling the patient with ice packs, 
administration of oxygen, and diuretics for cardiac failure, digoxin for 
uncontrolled atrial fibrillation sedation and intravenous hydrocortisone. 
Specific treatment is by carbimazole 10-20 mg 6 hourly, lugol’s iodine 10 
drops 8 hourly by mouth or sodium iodide 1 gm intravenously. Propronalol 
40 mg 6 hourly orally will block adverse betaadrenergic effects. This may be 
give by careful intravenous administration (1-2) mg under precise 
electrocardiographic control. 
Parathyroid insufficiency 
 This is due to removal of parathyroid glands or interference with their 
blood supply through trauma to parathyroid end artery. The incidence of this 
condition should be less than 0.5% and most cases present dramatically 2-5 
days after operation, but very rarely the onset is delayed for 2-3 weeks or a 
patient with marked hypocalcaemia is asymptomatic. It is commonly 
transient in nature and quickly controlled by calcium by mouth. If severe, 20 
ml of 20% solution of calcium gluconate is given intravenously i.e, (10 ml of 
10% ampoule) and later supplemented with oral calcium. 
Recurrent laryngeal nerve paralysis (63) 
 This may be unilateral or bilateral transient or permanent. Transient 
paralysis occurs in about 3% of the nerves at risk and recovers in about 3 
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weeks to 3 months. Permanent paralysis is extremely rare if the nerve has 
been identified at operation. If recovery does not take place within this 
period, organic injury to the nerve should be suspected. This may be due to 
stretching or bruising of the nerve or to its inclusion in a ligature, it is seldom 
divided. The prognosis regarding the recovery of function is poor if the 
nerve is divided. Repair of the nerve may be attempted, but the results are 
uncertain. 
Hypothyroidism 
 This usually occurs within 2 years but may be delayed for 5 years or 
more. It is often insidious and difficult to diagnose. The incidence is higher 
than used to be thought and figures of 20 to 45% have been reported after 
operations on toxic nodular goitres with internodular hyperplasia. It 
represents a change in the autoimmune response from stimulation to 
destruction of thyroid cells. Hypothyroidism commonly follows after sub-
total thyroidectomy for lymphocytic thyroiditis. The treatment consists of 
administration of L- Thyroxine 0.1mg to prevent myxedema after analyzing 
thyroid profile post operatively at 1 week and 1 month. 
Recurrent thyrotoxicosis(64) 
 This is due to either removal of inadequate thyroid tissue or to 
subsequent hyperplasia of the tissue that has been left. It is not uncommon in 
primary toxic goiter but very rare in the secondary thyrotoxicosis. Further 
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operation should be avoided if possible. The best results are obtained by 
radioiodine or by the anti-thyroid drugs. 
Other complications 
• Wound infection 
• Hypertrophic or Keloid Scar & Stitch granuloma. 
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METHODOLOGY 
 The present study of “clinical study and management of multinodular 
goiter” has been conducted by utilizing the cases diagnosed clinically as 
MNG and treated on inpatient basis in the department of General Surgery at 
PSG hospitals Coimbatore. It is a prospective study of all the cases clinically 
diagnosed as MNG of about 30 cases. 
 The patients were selected according to the inclusion and exclusion 
criteria as mentioned below. All these cases were studied in detail, clinically 
and recorded as per the proforma. The relevant investigations whenever 
indicated were performed. 
 The investigations included Hemoglobin percentage, urine analysis, 
blood sugar estimation, blood urea estimation, blood grouping and Rh 
typing, x-ray of the neck-AP and lateral views and chest X-ray and ENT 
examination. For all patients FNAC and thyroid profile was done per-
operatively. All patients underwent surgery and all the excised thyroid 
specimen were sent for Histo-pathological examination. Patients were 
discharged and were asked to come for follow up. They were advised to take 
the needful medications after surgery. 
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Inclusion criteria: 
1. Patients with enlargement of thyroid gland, with more than one nodule 
palpable or enlarged thyroid gland with nodular surface.  
2. Toxic and non- toxic multinodular goitres were included in the study. 
Exclusion criteria: 
1. Diffuse hyperplastic goiter. 
2.  Solitary nodule of thyroid. 
3.  Thyroid enlargement with the clinical features suggestive of 
malignancy. 
4.  Multi-nodular goitre patients not undergoing surgery were excluded. 
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RESULTS 
In the present study the maximum age recorded was 78 years and minimum 
age recorded was 28 years with the mean age . Highest incidence was 
observed in the age group 41- 50 years. 
 
                Age No. of patients Percentage 
 0-10 yrs 0 0 
     11-20 yrs 0 0 
     21-30 yrs 2 7 % 
     31- 40 yrs 5 16 % 
     41-50 yrs 12 41 % 
     51-60 yrs 5 16 % 
61 & above 6 20 % 
 
0
2
4
6
8
10
12
14
0-10 11-20 yrs 21-30 yrs 31-40 yrs 41-50 yrs 51-60 yrs 61& 
above
age distribution
age distribution
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SEX DISTRIBUTION: 
In total of 30 patients screened 28 of them were female and 2 of them 
male. 
Sex Number of patient Percentage 
Female 28 93 % 
Male 2 7% 
total 30 100 % 
 
 
 
 
 
sex distributation
female
male
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AGE AND SEX DISTRIBUTION 
Age in years Females Males No of case Percentage 
 0-10 yrs 0 0 0  
     11-20 yrs 0 0 0  
     21-30 yrs 1 1 2 7% 
     31- 40 yrs 5 0 5 16% 
     41-50 yrs 11 1 12 41% 
     51-60 yrs 5 0 5 16% 
61 & above 6 0 6 16% 
Total 28 2 30 100% 
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SYMPTOMATOLOGY 
Symptoms Total no. of patients Percentage % 
Swelling in front of neck  30 100 % 
Pain and discomfort  2 7 % 
Palpitation 3 10% 
Dyspnoea 0 0 
Dysphagia 4 13% 
Increased sweating 0 0 
Increased appetite 0 0 
Weight loss 2 7% 
Constipation 6 20% 
Weight gain 1 3% 
Change in voice 1 3% 
 
 All 30 patients all had commonest complaints of swelling the front of 
the neck. Out of them 10 had no complaints other than swelling. 
  
6 (20%) of them were having constipation, 4 (13%) of them dysphagia, 
3(10%) having palpitations, 2(7%) having weight loss, 2(7%) 
discomfort,       1(3%) having change in voice and 1(3%) having weight gain 
PHYSICAL SIGNS: 
Physical Signs 
Mobility with deglutition 
Left lobe enlargement 
Right lobe enlargement 
Both lobe enlargement 
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Number of Cases Percentage
 30 100%
 4 13%
 4 13%
 22 74%
signs
right lobe 
engarment both lobes 
enlargement
signs
 
 
 
 
 
 
 
signs
  
For 30 swelling moves with deglutition, 4(13%) of them had only right lobe 
enlarged, 4(13%) of them had left lobe and 22(13%) have both lobes 
enlarged. 
DISTRIBUTION OF SECONDARY THYROTOXICOSIS
Type of goiter 
Male
Nontoxic multinodular goiter
Toxic multinodular goiter
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Number of 
cases 
Total Percentage
 Female
 1 26 
 1 2 
Non toxic MNG
 
 
90% 
3% 
 
female
male
  
TYPES OF SURGERY DONE:
Type of surgery 
Total thyroidectomy  
Near total thyroidectomy
Subtotal thyroidectomy
Total 
 
 20(67%) of them under went total thyroidectomy, 6(20%) were 
preceded with subtotal thyroidectomy, and 4(13%) underwent near total 
thyroidectomy. 
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No of patients Percentage %
20 67%
 
4 13%
 
6 20%
30 100%
Procedure
Total thyroidectomy
near total thyroidectomy
Subtotal thyroidectomy
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POST OPERATIVE COMPLICATIONS: 
Type of complications No. of patients Percentage % 
Recurrent laryngeal nerve 
palsy (unilateral) 
3 10% 
Parathyroid insufficiency  8 27% 
Wound infection  0 0 
Primary Haemorrhage  0 0 
Mortality  0 0 
  
 21 had nil complications, 8(27%) out of 30 hypocalcaemia for which 
patients were managed with IV calcium gulconate and oral supplements and 
3(10%) had recurrent laryngeal nerve palsy and were managed with steroids, 
which was also improved on the day course. 
 
  
Investigations: 
 Fine needle aspiration cytology was done in all case. Nodular 
goiter was reported in 23 cases (77%). Hashimoto’s thyroiditis was reported 
in 5 cases (17%). 1 (3%) of the case which was clinically benign and another 
1 (3%) was reported as adenomatous nodule in a nodular goiter.
Diagnosis 
Nodular colloid goiter
Hasimoto’s thyroiditis
Follicular neoplasm
Adenomatous nodule
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No. of patients Percentage %
 
 23  77% 
 
5 17% 
 
1 3% 
 
1 3% 
Complications
 
colloid 
 
Complications
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 Indirect laryngoscopy was done in all the cases, and one patient was 
found to have left vocal palsy perioperatively. All other patients were found 
to be normal. 
 Thyroid profile was done in all patient and was suggestive of 
hypothyroidism in 3 cases, 1 had hyperthyroidism and in 26 were found to 
be normal. 
Histopathological analysis vs. FNAC: 
 According to histopathological analysis in present study of 30 cases, 
16cases (53%) showed features of benign colloid goiter, 8 (27%) 
Hashimoto's thyroiditis in that 4 (50%) were reported as colloid goiter in 
FNAC. 3(10%) out of 30 had features of both colloid goiter and hashimoto’s 
thyroiditis.  
 1 of the FNAC reported as follicular neoplasm HPE turned out to be 
adenomatous hyperplasia with hashimoto’s thyroiditis. 
 1 FNAC reported as adenomatous nodule in a nodular goiter and 
reported as minimally invasive follicular neoplasm.  
 1 case was reported as colloid goiter which was finalized as 
adnomatous goiter with papillary carcinoma in the right lobe. 
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DISCUSSION 
 The study which was conducted with aims of assessing clinical 
presentation, age, sex distribution, Symptomatology indication, 
complications of surgery and comparison of FNAC with histopathological 
analysis of 30 cases of MNG admitted to department of general surgery, 
PSG medical college and hospital. All cases were evaluated clinically and 
cytologically before the surgery and followed by histopathological analysis. 
Age distribution: 
 According to the study the maximum age presented here was 78 yrs 
and minimum was 28yrs all 30 patients were screened and most incidences 
were between the ages 40 to 50 years according to the study. 
  In the study conducted by Ahuja (65) majority of cases belong to the 
3rd and 4th decades. Raja Najum ul Haq (66) conducted a study of 718 more 
number of case belong to age group 40 to 50 years 261 patients (36.35%). 
The present study is similar when compared to the above studies. 
Sex distribution  
 It was observed in the current study out of 30 cases 28 were 
females(i.e. 93%)  and 2 were males with a sex ratio of female to male is 
14:1. Nygaard B (67) reported that out of 69 cases, 62 cases (89.9%) were 
females and 7 cases (10%) were males with sex ratio 8.8: 1. 
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 Study by Antonio Alfonso(68) showed a female to male ratio of 7: 1. 
In the study conducted by Ahuja (65), out of 205 cases 160 (78.1%) were 
females and 45 (21.9%) were males with a sex ratio of 3.5: 1. With Raja 
Najum ul Haq(66) female dominance was high 96.80%. In all above studies 
there is a female preponderance. When compared to the first two above 
studies was high and third study was almost similar and comparable. 
 Almost all the thyroid related disorders are common in women and 
MNG is not an exception, the reason being more TSH fluctuation seen in 
women during adolescence, pregnancy, child birth and so on. 
Symptomatology : 
 Swelling in front of the neck was how all the patients presented (100 
percent).       6 (20%) of them were having constipation, 4 (13%) of them 
dysphagia, 3(10%) having palpitations, 2(7%) having weight loss, 2(7%) 
having pain & discomfort,       1(3%) having change in voice and 1(3%) 
having weight gain.  
 All patients presented swelling in the front of the neck in that majority 
of the patient’s duration below 1 year was in 11 (36.67%) cases and below 5 
years was 14 (47%) cases .In 2 (6.67%) patients presented with duration 
more than 5 years.  
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 Involvement of both the lobes was seen in majority of patients 
22(74%). Predominant right lobe involvement was seen in 4 cases (13%). 
Left lobe involvement was seen in only 4 (13%) case. 
Investigations: 
 FNAC is considering as the common, cost effective, minimally 
invasive, low complication, pre operative tool in the evaluation of MNG. 
Nodular colloid goiter was reported in 23 cases (77%). Hashimoto’s 
thyroiditis was reported in 5 cases (17%). 1 (3%) of the case which was 
clinically benign and another 1 (3%) was reported as adenomatous nodule in 
a nodular goiter 
Surgical treatment: 
 All patient took part in the study underwent surgery, total 
thyroidectomy was carried out in 20(67%) patients, sub-total thyroidectomy 
was carried out in 6(20%) patients, and 4(13%) patients under went near 
total thyroidectomy. 
Post operative complications: 
Out of thirty patients those patients underwent 8(27%) out of 30 
hypocalcaemia in that 6 underwent went total thyroidectomy and 2 
underwent sub-total thyroidectomy for which patients were managed with IV 
calcium gluconate and oral supplements and 3(10%) had recurrent laryngeal 
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nerve palsy all underwent total thyroidectomy and were managed with 
steroids, which was also improved on the day course. 
Histopathology: 
 In histopathological analysis for the 30 cases was reported as 16cases 
(53%) showed features of benign colloid goiter, 8 (27%) Hashimoto’s 
thyroiditis. 3(10%) out of 30 had features of both colloid goiter and 
hashimoto’s thyroiditis. 
 In majority of the cases where the FNAC was benign it proved to be 
benign MNG on postoperative Histopathological examination. In those 2 
cases which was benign by FNAC and HPE was reported as malignancy. 
One such case reported as follicular neoplasm by FNAC was reported as 
benign. 
  A study by Arup Sengupta (69), in the FNAC, preponderance of the 
cases (75.84%) was colloid goitre followed by granulomatous thyroiditis; 
follicular carcinoma was noted in 7.30 percent and anaplastic carcinoma in 
3.37 percent of cases. Histopathological examination showed benign goitre 
predominantly (76.97%), followed by follicular carcinoma (8.99%). The 
overall prevalence of malignancy was 11.24 percent diagnosed by HPE and 
9.55 percent by FNAC. 
 When compared to the above study the results for the FNAC 
sensitivity is 91% accurate. 
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CONCLUSION 
1. Highest age incidence of multinodular goitre was observed in the age 
group 41 -   50 years (41%).  
2.  Females were predominant in number over males with the ratio of 
14:1.  
3. The commonest complaint was swelling in front of the neck (in 100 
percent of cases). Other symptoms were pain and discomfort, 
dysphagia, palpitation. dyspnoea, increased sweating, increased 
appetite and weight loss. 
4. FNAC was done in all patients which showed 91% sensitivity.  
5. The standard surgery done was Total thyroidectomy in 67% cases. 
Subtotal thyroidectomy in 20% of cases and near total 13% of case.  
6. Postoperative period was uneventful in all cases except in 11 cases, in 
whom 3 patients had unilateral recurrent laryngeal nerve palsy, and 8 
patients developed post operative hypocalcemia which also improved 
on the hospital day course with medications. 
7. Though total thyroidectomy was done in 67% case there is no rate of 
bilateral recurrent laryngeal nerve injury and unilateral injury is also 
less. 
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8. The hypocalcemia attack post operatively is 27% percentage which 
can be prevented by identification of parathyroids while doing thyroid 
surgery and preserves it.   
9. According to histopathological analysis in present study of 30 cases, 
16cases (53%) showed features of benign colloid goiter, 8 (27%) 
Hashimoto's thyroiditis in that 4 (50%) were reported as colloid goiter 
in FNAC. 3(10%) out of 30 had features of both colloid goiter and 
hashimoto’s thyroiditis. 1 of the FNAC reported as follicular neoplasm 
HPE turned out to be adenomatous hyperplasia with hashimoto’s 
thyroiditis.1 FNAC reported as adenomatous nodule in a nodular 
goiter and reported as minimally invasive follicular neoplasm. 1 case 
was reported as colloid goiter which was finalized as adnomatous 
goiter with papillary carcinoma in the right lobe. 
10. FNAC is an invaluable, minimally invasive highly accurate and cost 
effective procedure for preoperative assessment of patients with 
thyroid lesions. Even though follicular neoplasm cannot be 
differentiated by FNAC. 
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PROFORMA 
Case No : IP No. : Name : Ward No. : Age : Hospital : Sex : Unit : 
Occupation : D.O.A. : Address : D.O.S. : D.O.D. :  
CLINICAL DIAGNOSIS:  
I. PRESENTING COMPLAINTS  
a) Swelling in front of neck  
b) Pressure symptoms  
c) Symptoms of thyrotoxicosis or hypothyroidism d) other symptoms  
II. HISTORY OF PRESENT ILLNESS:  
a) Swelling in front of neck :  
- Duration  
- S ite  
- Size  
- Onset  
- Progression  
- Associated pain or discomfort  
b) Pressure Symptoms:  
- Dyspnoea  
- Dysphagia  
- Hoarsness of voice  
- Voice fatigue  
c) Symptoms of thyrotoxicosis or hypothyroidism  
- Anxiety  
- Fear  
- Palpitation  
- Precordial pain  
- Tremors - Fingers/Tongue  
- Sweating - Increased/Decreased  
- Weight - Increased/Decreased  
- Appetite - Increased/Decreased  
- Preference to heat/cold   
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- Diarrhoea/constipation  
- Exhaustion or strain  
- Lethargy  
- Loss of hair  
- Skin changes  
- Behavioral changes  
d) Other symptoms  
- Haemoptysis  
- Bony pain  
- Persistent headache  
III. PAST HISTORY  
Irradiation to head and neck in childhood  
IV. FAMILY HISTORY V. PERSONAL HISTORY  
Diet Appetite Sleep  
Bowel and bladder habits  
VI. MENSTRUAL HISTORY Flow __________ days  
Menoorhagia / amenorrhoea, oligomenorrhea  
VII. TREATMENT HISTORY  
VIII. 
GENERAL 
PHYSICAL 
EXAMINATI
ON : Pallor  
Icterus  Cyanosis  
Clubbing  Lymphadenopa
thy  
Oedema  
 
 
Vital signs :  
Pulse ________ Rate Rhythm, Tension, Volume, Character  
BP __________ mm of Hg  
Respiratory rate ______________ cycles / min  
Temperature 
IX. LOCAL EXAMINATION:  
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1) 
Inspection  
a) Situation  
b) Size  
c) Shape  
d) Extent  
e) Surface  
f) Borders  
g) Movement with deglutition  
h) Skin over the swelling – 
Colour, Scar, Sinuses  
Fungation  
Ulceration  
i) Visible pulsation j) Visible veins  
k) Surrounding area  
l) Any secondary changes  
2. PALPATION:  
a) Local rise of 
temperature  
b) Tenderness  
c) Site  
d) Shape  
e) Extent  
f) Sur face  
g) Borders  
h) Consistency  
i) Mobility  
j) Plane of the 
swelling  
k) Thrill  
l) Carotid pulsation  
m) Position of the 
trachea  
3. PERCUSSION : 
Sternum - Dull / 
Resonant  
4. 
AUSCULTATION 
:  
5. 
MEASUREMENT 
:  
6. TOXIC SIGNS : 
Toxic eye signs -  
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- Fine tremors in fingers/tongue  
- Moist skin 
 
X. SYSTEMIC EXAMINATION:  
1) RESPIRATORY SYSTEM  
2) CARDIO - VASCULAR SYSTEM  
3) PER ABDOMINAL EXAMINATION  
4) CENTRAL NERVOUS SYSTEM AND REFLEXES  
XI. CLINICAL DIAGNOSIS : XII. INVESTIGATIONS :  
1) ROUTINE - Hb%: TC:  
DC: ESR: Urine -Sugar: Albumin:  
Microscopy:  
- Blood urea  
- Serum creatinine  
- Fasting blood sugar  
- Blood grouping & typing  
- Serum cholesterol  
2) SPEICAL - Sleeping pulse rate  
- ECG  
- X- ray chest  
- X- ray neck AP & Lat. views  
- FNAC  
- Indirect laryngoscopy  
- Serum T3, T4 & TSH estimation  
- Others  
XIII. TREATMENT  
1) Medical line of treatment  
2) Surgical line of treatment  
XIV. HISTOPATHOLOGICAL DIAGNOSIS: XV. POST- OPERATIVE FOLLOW- UP 
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ANNEXURE – II 
CONSENT FORM FOR ANAESTHESIA/ PROCEDURE 
 
I………………………………….. Hosp.no………………….. in my full sense hereby give 
my complete consent for…………………………… or any other procedures deemed fit 
which is a /and diagnostic procedure /biopsy/transfusion/therapy to be performed on me/my 
son/my daughter/my ward…………………… age…....... under any anaesthesia deemed fit. 
The nature and risks involved in the procedure have been explained to me to my satisfaction. 
For academic and scientific purpose, the procedure may be televised or photographed.  
                                                  
 
                                        Signature/thumb impression of the patient/guardian  
 
Date:  
Name:  
Designation   
Guardian relationship:  
Full address: 
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Sl. 
No. 
 
 
 
I.P. No. 
 
 
 
Ag
e 
 
 
 
Sex 
 
 
 
Compln. 
 
 
 
Onset 
 
 
 
R.O.
G. 
 
 
 
Symp. 
 
Local  examination 
 
 
Signs of 
press 
& toxic 
 
 
 
I.D.
L 
 
 
 
T3,T4/ 
TSH 
 
 
 
FNAC 
 
 
 
Clinical 
diagnosis 
 
 
 
Sur.
Proc 
Move 
+ 
 
Size 
(cm) 
 
Shape 
 
Surface 
 
SON 
 
Cons. 
1 I13015391 41 F Swelling Insd. Grad constipario
n 
+ 8*5 B.fly Nod Both lobe FM Nil N WNL HT Nontoxic  
MNG 
STT
2 I13016809 48 F Swelling Insd. Grd constipation + 5x4 B.fly Nod Both lobe FM Nil N WNL HT Nontoxic  MNG STT
3 I13013269 28 F Swelling Insd. Grad Nil + 4x6 B.fly Nod Both. lobe FM Nil N WNL FNEO Nontoxic  MNG TT
4 I13027226 55 F Swelling Insd. Grad Diff.swall + 6x4 B.fly Nod Both lobe FM Nil N WNL NCG Nontoxic  MNG TT
5 I13015994 43 F Swelling Insd. Grad Nil + 4x5 B.fly Nod Both lobe FM Nil N WNL BCG MNG TT
6 I13025318 65 F Swelling Insd. Grad Nil + 2x5 B.fly Nod Rt. lobe FM Nil N WNL CG Nontoxic  
MNG 
TT
7 I13026114 39 F Swelling Insd. Grad Pain + 5x5 B.fly Nod Both lobe FM Nil N WNL CG Nontoxic  MNG TT
8 I13021777 78 F Swelling Insd. Grad Nil + 8x5 B.fly Nod Rt. lobe FM Nil N WNL CG Nontoxic  MNG TT
9 I13016097 47 F Swelling Insd. Grad Constipat + 8x5 B.fly Nod Both lobe FM Nil N WNL CG Nontoxic  MNG TT
10 I13028595 43 F Swelling Insd. Grad Nil  
+ 
 
3x3 
 
B.fly 
 
Nod 
Both lobe FM Nil N WNL C.LES MNG TT
11 I13026094 34 F Swelling Insd. Grad Change in 
voice 
+ 4x5 B.fly Nod Both lobe FM Nil N WNL CG Nontoxic  MNG TT
12 I13011913 78 F Swelling Insd. Grad Diff.swallo
w 
+ 8x8 B.fly Nod Both lobe FM Nil N WNL CG Nontoxic  MNG TT
13 I13010948 44 F Swelling Insd. Grad PAIN + 3x2 Sph Nod Left lobe FM Nil N WNL BCG Nontoxic  
MNG 
TT
14 I13007171 45 F Swelling Insd. Grad Dysp + 5x7 B.fly Nod Both lobe FM Nil N WNL NCG Nontoxic  
MNG 
STT
15 I13005459 52 F Swelling Insd. Grad Wt.ls + 4x4 oval Nod left lobe FM Nil N WNL NCG Nontoxic  
MNG 
NTT
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Sl. 
No. 
 
 
 
 
Ip no. 
 
 
 
 
Age 
 
 
 
 
Sex 
 
 
 
 
Compln. 
 
 
 
 
Onset 
 
 
 
 
R.O.G. 
 
 
 
 
Symp. 
 
 
Local  examination 
 
 
Signs of 
press 
& toxic 
 
 
 
 
I.D.L 
 
 
 
T3,T4/ 
TSH 
 
 
 
 
FNAC 
 
 
 
Clinical 
diagnosis 
 
 
 
Sur. 
Proc 
 
 
 
 
P.O.P 
 
 
 
 
H.P.E.
 
Move + 
deg. 
 
Size 
(cm) 
 
 
Shape 
 
 
Surface 
 
 
SON 
 
 
Cons. 
16 I13029706 37 F Swelling Insd. Grad Palpitation + 6x4 B.fly Nod Both lobe FM Nil N WNL HT Nontoxic  MNG STT UNFL HT 
17 I13012553 45 F Swelling Insd. Grad Nil + 5x7 B.fly Nod Both lobe FM Nil N WNL HT Nontoxic  MNG TT UNFL HT 
18 I13005421 30 F Swelling Insd. Grad Palpitation + 6x7 B.fly Nod Both. lobe FM Nil N WNL CG Nontoxic  MNG NTT UNFL HT 
19 I13036787 31 F Swelling Insd. Grad Wt.gain + 11x6 B.fly Nod Both lobe FM Nil N WNL NCG Nontoxic  MNG TT UNFL NCG HT 
20 I13035127 34 F Swelling Insd. Grad Nil + 6x3 B.flyl Nod Both. lobe FM Nil N WNL NCG Nontoxic  MNG STT UNFL NCG HT 
 
 
21 
 
 
I13030862 
 
 
70 
 
 
F 
 
 
Swelling 
 
 
Insd. 
 
 
Grad 
constipation  
 
+ 
 
 
10x7 
 
 
B.fly 
 
 
Nod 
 
 
Both. lobe 
 
 
FM 
 
 
Nil 
 
 
N 
 
WNL 
 
 
NCG 
 
 
Toxic MNG 
 
 
NTT 
 
 
UNFL 
 
 
NCG 
22 I13024119 41 F Swelling Insd. Grad Nil + 4x3 Oval Nod Both. lobe FM Nil N WNL CG Recrr .HT RT UNFL HT 
23 I13019554 56 F Swelling Insd. Grad Wt.loss. + 6x4 B.fly Nod Both lobe FM Tach + N  CG MNG TT UNFL HT 
24 I13005411 42 F Swelling Insd. Grad Nil + 2x2 oval Nod Rt lobe FM Nil N WNL Ade.n NG Nontoxic  MNG NTT UNFL NG 
25 I13022528 49 F Swelling Insd. Grad Nil + 5x3 B.fly Nod Both lobe FM Nil N WNL CG Nontoxic  MNG STT UNFL NG 
26 I13037379 65 F Swelling Insd. Prog DOE + 4x5 B.fly Nod Both lobe FM Nil N WNL CG Nontoxic  MNG TT Wound inf. MNG 
27 I13005610 60 F Swelling Insd. Grad Constipation + 2x2 B.fly Nod Left. lobe FM Nil N WNL NCG Nontoxic  MNG TT UNFL NCG 
28 
 
I13015994 63 F Swelling Insd. Grad Nil + 6x3 b.fly Nod Both.Lobe FM Nil N WNL BCG MNG TT UNFL NG 
 
 
29 
 
 
I13007359 
 
 
48 
 
 
F 
 
 
Swelling 
 
 
Insd. 
 
 
Grad 
Nil  
 
+ 
 
 
4x3 
 
 
B.fly 
 
 
Nod 
 
 
Rt. lobe 
 
 
FM 
 
 
Tach + 
 
 
N 
 
WNL 
 
 
NCG 
 
 
Toxic MNG 
 
 
TT 
 
 
UNFL 
 
 
NCG 
30 I13009629 53 F Swelling Insd. Grad constipation + 3x2 B.fly Nod Both. lobe FM Nil N WNL NCG Nontoxic  MNG TT UNFL NCG 
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KEY TO MASTER CHART 
 App   - Appetite  
 B.fly   - Butterfly  
 B/L RLN Pls -  Bilateral Recurrent laryngeal palsy  
 Bos  -  Bosselated  
 CC   - Cystic changes  
 Clinic Diag -  Clinical diagnosis  
 Const  -  Consistency 
 Dysp  -  Dyspnoea 
 Dysph  - Dysphagia  
 F/M   - Female/Male  
 Fm  - Firm  
 FNAC  -  Fine needle aspiration cytology  
 Grad  -  Gradual  
 HPE   - Histo-pathological Examination  
 HT   - Hashimoto’s Thyroiditis  
 IDL  - Indirect Laryngoscopy  
 Infn   -  Infection present  
 Insd  -  Insidious  
 Irr  - Irregular  
 Lt  -  Left  
 MNG  -  Multi nodular Goitre 
 Move+deg -  Movement with deglutition  
 N  - Normal  
 NCG   - Nodular Colloid Goitre  
 NG   - Nodular Goitre  
 Nod  -  Nodular  
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 TT   - Total Thyroidectomy  
 Palp  - Palpitation  
 POP  -  Post-operative Period  
 ROG   - Rate of Growth  
 Rt   - Right  
 SIFON  - Swelling in front of neck  
 Signs Of Pres&toxi -Signs of Pressure & Toxicity  
 SON   - Site of nodule  
 St   - Soft  
 STT  -  Subtotal Thyroidectomy  
 Sur. Proc  - Surgical Procedure  
 Surf  - Surface  
 Sw  - Sweating  
 Syms Of Press & Toxi- Symptoms of pressure and toxicity  
 Tachy  -  Tachycardia  
 UNFL  - Uneventful  
 WNL   - Within Normal Limits  
 Wt.loss -  Weight loss. 
 
 
